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 I 
 
Riassunto 
 
Il gene rpL3 produce, oltre all‟isoforma canonica di mRNA che verrà 
tradotta in proteina, un‟isoforma alternativa, sottoposta alla degradazione da 
parte dell‟NMD (Nonsense mediated mRNA decay), in quanto presenta un 
PTC (premature termination codon). Inoltre, l‟iperespressione della proteina 
rpL3 determina un incremento del livello dell‟isoforma alternativa, non 
produttiva, che ha come conseguenza la diminuzione di rpL3 (Cuccurese et 
al. 2005). Tale feedback negativo innescato dall‟accumulo della proteina 
ribosomale, rappresenta una strategia che regola finemente la quantità di 
proteina ribosomale ad un livello appropriato, soprattutto rilevante per 
eventuali funzioni extra-ribosomali della proteina rpL3. 
L‟ attività da me svolta durante il dottorato è stata indirizzata alla  
comprensione del ruolo di alcuni putativi interattori proteici di rpL3 e del 
suo trascritto primario identificati mediante spettrometria di massa sui 
prodotti di esperimenti di “GST Pull Down” e “RNA Pull Down”, quali 
hnRNP H1, NPM e KHSRP, nella regolazione post-trascrizionale del gene 
di rpL3. 
Con l‟ausilio di approcci bioinformatici, sono stati individuati degli 
elementi cis-acting, detti elementi G-run, nell‟introne 3 del gene rpL3 
coinvolto nello splicing alternativo. Tali G-run contribuiscono ad indirizzare 
la scelta di siti di splicing alternativi (Marcucci et al. 2007), interagendo con 
fattori proteici appropriati. Io ho dimostrato in vitro la capacità di legame di 
hnRNP H1 al trascritto primario del gene rpL3, utilizzando il saggio 
“REMSA” (RNA Electrophoretic Mobility Shift Assay). 
 II 
 
Poiché era stato dimostrato che gli elementi G3 e G6 (Napolitano, tesi 
di dottorato 2010) sono importanti per innescare lo splicing alternativo, ho 
studiato in seguito a transfezioni in transiente l‟effetto di iperespressione di 
hnRNP H1 in presenza di tali elementi G-run mutagenizzati. 
Successivamente attraverso esperimenti in vivo di 
immunoprecipitazione ed in vitro di “GST Pull Down” ho definito le 
relazioni che intercorrono tra le proteine hnRNP H1, NPM, KHSRP e rpL3, 
e il loro ruolo nel promuovere la selezione del sito di splicing (canonico o 
alternativo) sul trascritto del gene rpL3. 
In cloni stabili di cellule PC12 (cellule di feocromocitoma di ratto) che 
esprimono in maniera inducibile rpL3 mediante sistema tet-off, ho effettuato 
esperimenti di iperespressione delle proteine e valutato tramite RT-PCR 
l‟effetto di ciascuna di esse sulla produzione della quota di trascritto 
alternativo del gene di rpL3 (rpL3-a), sia in condizioni basali sia di 
iperespressione di rpL3. Analogamente, ho stimato l‟effetto su rpL3-a anche 
in seguito a silenziamento delle stesse proteine, mediante RNA-interference 
e successiva analisi per RT-PCR. 
Gli esperimenti effettuati hanno dimostrato che hnRNP H1, NPM e 
KHSRP sono coinvolte con ruoli diversi nella regolazione post-
trascrizionale del gene di rpL3 e ci hanno permesso di ipotizzare un modello 
di regolazione (Russo et al. 2011) che prevede una sequenza di interazioni 
tra queste proteine e il trascritto. 
Tale regolazione post-trascrizionale che vede coinvolta l‟associazione 
dello splicing alternativo con l‟NMD può essere molto rilevante per 
modulare in maniera fine la quota della proteina ribosomale rpL3 
disponibile per assolvere a funzioni extra-ribosomali. Ci sono infatti sempre 
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più evidenze di proteine ribosomali che hanno ruoli extra-ribosomali; in 
particolare noi abbiamo dimostrato la capacità di rpL3 di regolare la propria 
produzione innescando lo splicing alternativo. Inoltre dati preliminari 
ottenuti in laboratorio indicano una seconda funzione extra-ribosomale di 
rpL3 che appare coinvolta nel meccanismo di regolazione dell‟espressione 
di p21 indipendente da p53. 
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Summary 
 
In addition to canonical mRNA isoform  normally translated in to 
protein, rpL3 gene produces an alternative mRNA isoform, containing a 
PTC (premature termination codon) degraded by NMD (Nonsense mediated 
mRNA decay). 
 Overexpression of rpL3 causes an increase in the level of alternative 
unproductive, mRNA isoform, which results in a decrease of rpL3 
production (Cuccurese et al. 2005). This negative feedback loop triggered 
by the accumulation of the ribosomal protein, represents a strategy that 
finely  regulates the amount of ribosomal protein to an appropriate level, 
especially relevant to extra-ribosomal functions of rpL3. 
For my PhD project I worked to understand the role of some putative 
protein interactors (hnRNP H1, NPM and KHSRP) of rpL3 and its primary 
transcript. The protein factors were identified by mass spectrometry on the 
products of "GST Pull-Down" and "RNA Pull Down"  experiments, and my 
work aimed to clarify the role of these proteins in the post-transcriptional 
regulation of rpL3 gene. 
Through bioinformatics approaches, we have identified cis-acting 
elements, called G-run elements, within intron 3 of rpL3 gene involved in 
the alternative splicing. These G-run elements cooperate to direct the choice 
of alternative splice sites (Marcucci et al. 2007), through interactions with 
appropriate protein factors. I have shown, in vitro, the ability of hnRNP H1 
to bind rpL3 primary transcript, using  "REMSA" (RNA electrophoretic 
mobility shift assay). 
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Because it was demonstrated that the elements G3 and G6 
(Napolitano, Ph.D. thesis 2010) are relevant to trigger alternative splicing, I 
have studied with transient transfections the effect of hnRNP H1  
overexpression in  presence of mutated G-run elements. 
Then, through in vivo experiments of immunoprecipitation and in 
vitro experiments of "GST Pull Down", I have defined the relationships 
between hnRNP H1, NPM, KHSRP and rpL3, and their role in promoting 
the selection of splice site (canonical or alternative) on the rpL3 gene 
transcript. In stable clones of PC12 cells (rat pheochromocytoma cells) 
expressing rpL3 in an inducible mode (tet-off system), I have carried out 
experiments of protein overexpression and evaluated by RT-PCR the effect 
of each protein on the production of the alternative transcript of rpL3 gene 
(rpL3-a), both in basal conditions and in condition of rpL3 overexpression. 
Similarly, I have evaluated the effect on rpL3-a after silencing each protein 
by using RNA-interference and subsequent analysis by RT-PCR. 
Experiments have shown that hnRNP H1, NPM and KHSRP are 
involved with different roles in the post-transcriptional regulation of rpL3 
gene and allowed us to propose a model of regulation (Russo et al. 2011) 
that predicts a sequence of interactions between these proteins and the 
transcript. 
This strategy of post-transcriptional regulation, through the association 
of alternative splicing and NMD, can be very important to finely modulate 
the rpL3 amount available to extra-ribosomal functions. In fact, more and 
more evidences demonstrate that ribosomal proteins can exert extra-
ribosomal function.  
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As far as rpL3 is concerned, we have demonstrated the rpL3 ability to  
regulate its production by triggering alternative splicing. In addition, 
preliminary data obtained in our laboratory indicate that rpL3 is involved in 
a regulatory mechanism of p21 expression independent from p53. 
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1. Introduction 
 
1.1 Ribosomal protein expression 
The biosynthesis of ribosomes requires the coordinated espression of 
the genes coding for their structural components, rRNA and r-proteins. 
Control mechanisms are also necessary to maintain ribosome synthesis at 
the level appropriate to the requirements and growth conditions of the cell.  
Early studies of mammalian r-protein gene promoters showed that 
transcriptional activity is approximately equivalent and there are no shared 
elements (Hariharan et al. 1989). More recent in silico analyses found some 
recurring motifs in the transcriptional control regions (Perry, 2005; Ishii et 
al. 2006). However, besides some variation of r-proteins transcript levels in 
different tissues and in neuronal differentiation, transcriptional regulation 
does not appear to play a major role in the control of r-protein synthesis. On 
the other hand the rp-genes expression depends upon many factors (Loreni 
et al., 1993) and is finely tuned mostly by post-transcriptional and 
translational regulatory mechanisms. 
Although r-proteins have long been studied as ribosome components, 
a growing amount of data demonstrate that many r-proteins exert additional, 
extraribosomal functions; these findings add more relevance to the 
multiplicity of mechanisms discovered to finely tune the rp-genes 
expression. In humans, it has been shown that the interaction of 
mitochondrial rpL12 with mitochondrial RNA polymerase modulate gene 
expression in mitochondria (Wang et al., 2007). Moreover, many data 
indicate that in eukaryotes some r-proteins autoregulate their gene  
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expression through various mechanisms. Post-transcriptional regulations 
have been described that control the level of rp-mRNA in the cell through 
modulation of transcript processing, splicing and stability.  In S. cerevisiae, 
rpL32 regulate both splicing and translation of its mRNA (Dabeva and 
Warner, 1993). In C. elegans, rpL12 is able to down-regulate the canonical 
splicing and up-regulate an alternative splicing of its pre-mRNA (Mitrovich 
and Anderson, 2000). In humans, available data show that some r-proteins 
are able to modulate their own production by regulating alternative splicing 
(Cuccurese et al., 2005; Malygin et al., 2007). 
 
1.2 Regulation of processing of gene transcript 
Alternative splicing (AS) is a main regulatory mechanism of gene 
expression by which is produced a repertoire of mRNAs, and consequently 
of proteins, much larger than expected from the number of genes 
(Grawboski and Black, 2001). The different steps leading to gene products 
are integrated and coordinated reaching a high efficiency, and RNA 
surveillance mechanisms are present to provide correct gene products 
(Orphanides and Reinberg, 2002). 
Although the mechanisms of the AS have been extensively studied, 
the complex regulation of such process is still an issue. The complexity of 
the regulation pathways is due to an intricate and dynamic network of 
protein-protein and RNA-protein interactions. Changes in the activity, 
number, and association of splicing factors in the network can modify the 
selection of the splice site and the activity of the splicing machinery, and 
therefore the splicing pattern of the target pre-mRNA.  
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The regulation of pre-mRNA splicing plays an important role in 
human pathologies (Licatalosi and Darnell, 2010). Impairment of the AS is 
closely related to some disease mechanisms as in the case of spinal 
muscular atrophy and myotonic distrophy. Recently, new therapies aimed to 
correct defects arising in pre-mRNA splicing, the so-called „splice-
correction‟ or „splice-modulation‟ therapies, have been developed (Wood et 
al., 2010). 
Alternative splicing is modulated by cis-elements in intron or exon 
sequences that, associated with specific transacting factors, can negatively 
or positively affect splicing (Black, 2003). Exon cis-elements (ESE) differ 
in sequence; however, the consensus sequence (GAR)n can be drawn for the 
most frequently observed. The esanucleotide UGCAUG is a frequent 
element (Lim and Sharp, 1998, Black, 2003) in the intronic splicing 
enhancing sequences (ISE). ISE sequences frequently appear as a complex 
combination of multiple elements that mediate positive or negative effects 
on gene splicing (Modafferi and Black, 1997; Chan and Black, 1997). Other 
interesting intronic motifs include a stretch of three or four Gs (Nussinov et 
al., 1989); these sequence motifs have been shown to affect the splicing of 
chicken beta-tropomiosin gene (Sirand-Pugnet et al., 1995), of beta-globin 
gene (McCullough and Berget, 1997) and of human growth hormone gene 
(McCarthy et al., 1998). 
Interaction of cis-elements with specific transacting proteins may 
exert positive or negative effects on gene splicing. Splicing activating 
factors frequently belong to the SR protein family, while different protein 
components of hnRNP repress splicing upon binding to cis-elements (Sun et  
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al, 1993; Chen et al., 1999; Expert-Bezancon et al., 2004). SR proteins share 
features such as one or two RNA recognizing motif (RRM) and a domain 
containing the serine-arginine dipeptide. SR proteins activate splicing by 
binding to ESE sequences and enhancing recruitment of splicing machinery 
factors on the 3‟-splice site (Wang et al., 1995). 
The accuracy of the AS depends on the stoichiometry and interactions 
of positive and negative regulatory proteins. Consequently, the 
identification of the proteins participating in the modulation of the AS is an 
essential step to study the many aspects of gene expression. 
AS can also control gene expression quantitatively by generating 
unproductive mRNAs that are targeted for decay by nonsense-mediated 
decay (NMD) (McGlincy and Smith 2008).  
 
1.3 Nonsense-mediated mRNA decay (NMD) 
NMD is a surveillance pathway that detects and selectively degrades 
aberrant mRNAs harboring a premature termination codon (PTC), thus 
preventing the production of truncated polypeptides potentially deleterious 
to the cell (Fig. 1.1). 
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Figure 1.1: Nonsense-mediated mRNA decay (NMD). 
Normally, an EJC is removed from the ribosome during the pioneer 
round. If upstream from an EJC a nonsense codon (PTC) is present, the EJC 
will not be removed from the ribosome and thus will trigger NMD-mediated 
degradation. 
 
PTC may arise through a nonsense or frameshift mutation of DNA, as 
a consequence of DNA rearrangement, or, more often PTCs are a 
consequence of splicing errors producing aberrant mRNAs (Wagner and 
Lykke-Andersen, 2002). NMD is highly conserved in eukaryotes; many 
studies have dissected machinery components, and the issue of its 
localization in a cell compartment has been thoroughly discussed (Chang et 
al, 2007; Nicholson et al., 2010; and references therein). In the nucleus, 
several proteins take part in the assembly of a large molecular complex 
deposited at each exon-exon junction (EJC). Such mRNP complex, 
rearranged, and including other transiently associated proteins moves to the  
Introduction 
 
6 
 
 
cytoplasm where a mRNA scanning by the translational apparatus will take 
place by mean of a pioneer round of translation. EJCs will be removed 
during the pioneer round of translation, which stops at the PTC thus leaving 
unremoved EJC sitting on exon-exon junction downstream from the PTC. 
The up-frameshift protein 1 (UPF1) is recruited on the unremoved EJC, and, 
following interactions between UPF1 and NMD factors, the decay process 
initiates. UPF1 shows elicase activity, and undergoes phoshorylation and 
dephosphorylation rounds; although it has been shown that UPF1 is 
essential to initiate NMD, its role in the process is still unknown. 
 
1.4 AS-NMD association 
Alternative splicing can quantitatively control gene expression by 
producing PTC containing mRNAs, unproductive, degraded by NMD. The 
association AS-NMD which results in a quantitative regulation of the 
productive RNA abundance has been shown to be effective in the 
expression of many genes (Green 2003). In fact, the process regulating gene 
expression through AS-NMD association has been defined RUST 
(Regulated Unproductive Splicing and Translation; Lewis et al., 2003).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 Data from several laboratories demonstrate that some alternative 
isoforms of mRNA encoding ribosomal proteins (rp) are NMD substrates. 
In Caenorhabditis elegans, it has been shown that the AS of genes rpL3, 
rpL12, rpL10 and rpL7 gives raise to aberrant mRNA isoforms, which 
contain a PTC resulting from an incomplete intron removal, and are natural 
substrate of NMD (Pulak and Anderson, 1993). The AS event appears 
conserved in humans and in other mammals on rpL3 and rpL12 genes. In  
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fact, previous data from the laboratory where I carried out my thesis studies 
demonstrated that human rpL3 gene transcript gives rise to a canonical 
mRNA and to an alternative mRNA isoform containing a PTC targeted to 
decay by NMD. rpL3 is able to modulate its own production via a negative 
feedback loop. In fact, rpL3 overexpression results in a decreased level of 
the canonically spliced mRNA, and an increased production of the 
alternatively spliced isoform (Fig. 1.2; Cuccurese, 2005). 
 
 
Figure 1.2: Model for rpL3 feedback regulation. 
 A canonically spliced isoform will be translated to produce rpL3 
protein. The alternative mRNA isoform is unproductive and will be 
removed by NMD. When present in excess, rpL3 down-regulates canonical 
splicing and up-regulates the alternative splicing of its own pre-mRNA. 
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1.5 Aim of the studies 
These results raised the issue of identifying molecular partners of rpL3 
involved in the splicing event. Data showing that rpL3 is unable to bind its 
own gene transcript, led to the working hypothesis that rpL3 modulates the 
splicing of its gene by interacting with one or more regulatory proteins. 
Since the accuracy of the AS depends on the stoichiometry and interactions 
of positive and negative regulatory proteins, the identification of proteins 
participating in the modulation of the AS of rpL3 gene appeared an essential 
step to understand the regulation of this gene.  In fact GST-pull down and 
RNA-pull down assays followed by Mass Spectrometry analysis confirmed 
that many putative rpL3 and intron 3 interactors were present in human cell 
extracts (Fig. 1.3; Russo A. et al., 2010). 
Among others, the heterogeneous nuclear ribonucleoprotein hnRNP 
H1 was identified as a transacting factor able to interact in vitro and in vivo 
with rpL3 and with intron 3 transcript of the rpL3 gene. Further data 
demonstrated that hnRNP H1 is involved in promoting the AS of human 
rpL3 pre-mRNA. In addition, the same group  identified and characterized 
the cis-acting regulatory elements, G runs, involved in hnRNP H1-mediated 
regulation of splicing (Russo A. et al., 2010). For my thesis project, I  have 
analyzed the role of hnRNP H1 in the rpL3 autoregulatory loop, and 
identified two new regulatory proteins, KHSRP (K-homology splicing 
regulatory protein, also known as KSRP) and NPM (B23, numatrin or 
NO38), which exhibit opposite effects on the splicing reaction of rpL3 pre-
mRNA. The data reported here contribute to the laboratory effort to shed  
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light on protein-protein and RNA-protein interactions within putative RNP 
complexes involved in the modulation of splicing of the rpL3 gene. 
 
                 
 
 
Figure 1.3: Mass-spectrometry analysis  
rpL3 and intron 3 RNA interacting proteins identified by mass-
spectrometry analysis of products of GST- and RNA-pulldown experiments  
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2. Materials and Methods 
 
2.1 Cell cultures, transfections and drug treatment 
Human cell line HeLa was cultured in Dulbecco‟s Modified Eagle‟s 
Medium (DMEM) with glutamax, supplemented with 10% fetal bovine 
serum (FBS), 2mM L-glutamine and penicillin–streptomycin 50 U/mL.  
L3–8 cell line, derived from rat PC12 Tet-Off cell line and 
conditionally overexpressing rpL3 upon doxycyclin removal, was grown in 
DMEM supplemented with 5% fetal calf serum (FCS), 10% horse serum, 
2mM L-glutamine and 100 mg/mL G418, hygromycin 200 mg/mL and 
doxycyclin 10 ng/mL. The expression of HA-rpL3 was induced upon 
removal of doxycyclin. siRNA transfections were performed in HeLa cells 
(1 x 10
6
 cells, 6mm well plate) at a concentration of 150nM by using 
Oligofectamine Reagent (Invitrogen) according to the manufacturer‟s 
instructions. Plasmids were transfected in L3–8 cell line or in HeLa cells 
(2.5 x 10
6
 cells, 6mm well plate) by using Lipofectamine 2000 (Invitrogen) 
according to the manufacturer‟s instructions. Twenty-four hours after DNA 
or siRNA transfections, cells were treated with 100 mg/ml cycloheximide 
(CHX) for 4 h to block NMD. Then, RNA and proteins were extracted by 
using the Trizol procedure (Invitrogen) for RT–PCR analysis and western 
blot, respectively. 
 
2.2  DNA constructs and production of recombinant proteins 
The intron 3, regions A, B and C of intron 3 of rpL3 pre-mRNA were 
obtained by RT-PCR using specific primers and cloned into the pGEM-4Z  
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vector to obtain constructs pGEM4Z-Int3, pGEM4Z-IntA, pGEM4Z-IntB 
and pGEM4Z-IntC, respectively. The primers used were: Int3 5‟-
AATTGGTAAGGGAGGAG-3‟ and 5‟-TATGCCTTCAGGAGCAGA-3‟; 
IntA 5‟-AAGAATTGGTAAGGGAGG-3‟ and 5‟-
GGAAGCCCACTCAGTGAT-3‟; IntB 5‟-CCAGGGCAAAAGGTTTG-3‟ 
and 5‟-GTAAAGGCCTTCTTCTTAG-3‟; IntC 5‟-
AAGAATTGGTAAGGGAGG-3‟ and 5‟-TCAGAATGAGGGTGTTAGC-
3‟. The cDNAs of hnRNP H1, rpL3 and NPM were obtained by RT-PCR 
from HeLa cells using specific primers and cloned into the prokaryotic 
expression vector pGEX4T3. The primers used were: GST-hnRNP H1 5‟-
ATGATGTTGGGCACGGAA-3‟ and 5‟-CTATGCAATGTTTGATTG-3‟; 
GST-rpL3 5‟-ATGTCTCACAGAAAGTTC-3‟ and 5‟-
AGCTCCTTCTTCCTTTGC-3‟; GST-NPM 5‟-
ATGGAAGATTCGATGGAC-3‟ and 5‟-TTAAAGAGACTTCCTCCA-3‟.  
The cDNA of hnRNP H1 and NPM were also cloned into a version of 
the eukaryotic expression vector pcDNA4/HisMax C (Invitrogen) 
containing the HA epitope, and into the prokaryotic expression vector 
pRSET-A (Invitrogen) containing the Histidine tag. Flag-KHSRP and His-
KHSRP were already available (Gherzi 2004). The recombinant proteins 
GST-hnRNP H1, GST-rpL3 and GST were expressed in Escherichia coli 
and purified by using glutathione Sepharose 4B beads according to the 
manufacturer‟s instructions (GE Healthcare). The recombinant proteins His-
NPM, His-hnRNP H1 were expressed in E. coli and purified by the nickel–
nitrilotriacetic acid (Ni–NTA)-Agarose chromatography according to the 
manufacturer‟s instructions (Qiagen, Valencia, California). His-tagged  
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KHSRP was expressed in Sf9 cells using the Baculovirus system 
(Baculogold, BD Biosciences) and purified by Ni–NTA-Agarose 
chromatography (Gherzi, 2004). 
 
 
2.3 RNA electromobility shift assay (REMSA) 
RNA probes were transcribed in vitro using 
32
P-NTPs and SP6 
polymerase according to the manufacturer's instructions (Roche), and 
construct pGEM4Z-IntA, pGEM4Z-IntB, or PGEM4Z-IntC as template. 
The probes were purified using Sephadex G-25 columns. 5×10
5
 
counts/min of each RNA probe were incubated in binding buffer containing 
20 mM Hepes, pH 7.9, 150 mM KCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.1% 
Triton, 1 mg/mL tRNA, and 0.4 U/μL RNase Inhibitor in the presence or 
absence of the recombinant protein GST-hnRNP H1 or GST for 1 h at 4 °C. 
The complexes formed were then resolved onto a 5% polyacrylamide 
(37.5:1 acrylamide:bisacrylamide ratio) RNA native gel. The gel was dried 
at 80 °C for 30 min and the results visualized by autoradiography. 
 
2.4 RNA interference 
The target sequences of small interfering RNAs (siRNA) in hnRNP 
H1 were: 5‟-GGAAATAGCTGAAAAGGCT-3‟ and 5‟-
CCACGAAAGCTTATGGCCA-3‟. The siRNAs targeting NPM and 
KHSRP were purchased from Santa Cruz Biotechnology. 
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2.5 GST and RNA pull-down assay 
For GST pull-down assay, 50 µg of the fusion protein or GST control, 
as bait were immobilized on glutathione-Sepharose beads and incubated 
with 20 µg of the recombinant protein of interest in pull-down buffer 
(50mM Tris–HCl, pH 7.5, 0.4mM EDTA, 150mM NaCl, 10% glicerol, 1% 
NP-40, 1mM sodium-ortovanadate, 50mM NaF, 5mM DTT and Protease 
Inhibitor Mix 1x) at 4 °C for 1.5 h. The beads were washed extensively and 
boiled in SDS sample buffer. The eluted proteins were loaded on 12% SDS–
PAGE and analyzed by western blotting. 
RNA pull-down assay was carried out by using adipic acid 
dehydrazide beads. 20 µg of intron 3 RNA, transcribed in vitro from 
pGEM4Z-Int3, were placed in a 400 µL reaction mixture containing 100 
mM NaOAc pH 5.2 and 5mM sodium m-periodate (Sigma), incubated for 1 
h in the dark at room temperature, ethanol precipitated and resuspended in 
100 µL of 100 mM NaOAc, pH 5.2. Then, 300 µL of adipic acid 
dehydrazide agarose beads 50% slurry (Sigma) equilibrated in 100 mM 
NaOAc pH 5.2 were added to this mixture, which was then incubated for 12 
h at 4 °C on a rotator. The beads with the bound RNA were pelletted, 
washed twice with 1 mL of 2M NaCl and equilibrated in washing buffer 
(5mM HEPES pH 7.9, 1mM MgCl2, 0.8mM magnesium acetate). The 
intron 3 RNA was then incubated with 50 µg of each recombinant protein 
for 30 min at room temperature in a final volume of 0.6 mL. The beads were 
then washed four times in 1.5 mL of washing buffer. Bound proteins were 
eluted in SDS sample buffer loaded on a 12% gel for SDS–PAGE and 
analyzed by western blotting. 
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 2.6 Immunoprecipitation and western blotting 
 For immunoprecipitation assay, 1 mg of HeLa whole-cell lysate was 
incubated with 30 µL of protein A/G agarose beads coated with 5 µg of 
anti-NPM or anti-KHSRP (Santa Cruz Biotechnology) at 4 °C for 12 h. The 
beads were washed and boiled in the SDS sample buffer. The eluted 
proteins were loaded on 12% SDS–PAGE and detected by western blotting. 
Aliquots of protein samples (30 µg) were resolved by 12% SDS–gel 
electrophoresis and transferred into nitrocellulose filters. The membranes 
were blocked in PBS, 0.1% Triton and 5% dry milk for 2 h, and then 
challenged with anti-NPM, anti-KHSRP, anti-hnRNP H1, anti-HA, anti-
Flag (Santa Cruz Biotechnology) anti-rpL3 and anti-rpL7a (Primm). The 
proteins were visualized with enhanced chemiluminescence detection 
reagent according to the manufacturer‟s instructions (Pierce). 
 
 2.7 RNP immunoprecipitation assay 
For RNP immunoprecipitation assay (RIPA), HeLa cells (2 x 10
6
 
cells) were lysed in 600 µL RIPA buffer 1x (10mM Tris–HCl pH 7.5, 
150mM NaCl, 0.1mM EDTA, 1mM Na ortovanadate, 0.05M NaF, 0.5% 
NP-40) with protease inhibitors mix 1x (Roche) for 60 min on ice, and then 
centrifuged at 10 000 g at 4 °C for 15 min. The supernatant was subjected to 
a pre-clearing step in which it was incubated with 50 µL of protein A/G plus 
agarose for 1 h at 4 °C. The pre-cleared cell extracts were then incubated 
with antibodies specific for each protein (Santa Cruz Biotechnology) 
overnight at 4 °C. Protein A/G plus agarose beads (50 µL of 50% slurry) 
were then added and the mix was incubated for 1 h at 4 °C with gentle  
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shaking and centrifuged. The immunoprecipitates were suspended in 100 µL 
TES buffer (10mM Tris–HCl pH 7.5, 0.5mM EDTA, 0.5% SDS), incubated 
at 65 °C for 10 min and centrifuged for 1 min at 10 000g. Ten microliters of 
the supernatant were stored as immunoprecipitated samples and 
subsequently fractionated by SDS–PAGE to be analyzed by western 
blotting. RNA was extracted from 90 µL using the Trizol procedure 
(Invitrogen). 
 
2.8 RT-PCR 
For RT–PCR analysis, 1 µg of total RNA was reverse transcribed into 
cDNA with the random hexamers technique using 200U of Superscript II 
RNAse H
-
 Reverse Trancriptase (Invitrogen). The reaction was carried out 
at 42 °C for 50 min and was terminated by heating to 75 °C for 15 min. Ten 
of the 40 µL of reaction mix were PCR amplified in a final volume of 50 
µL, using 5 mM of each specific primer, 10mM dNTPs and 0.5U of Taq 
DNA polymerase (Invitrogen). Typically, 25–30 cycles of amplification 
were performed. The primers were: rpL3-a 5‟-
CTCCGCTGGGCTCTGCCC-3‟(forward) and 5‟-
CTTCAGGAGCAGAGCAGA-3‟ (reverse); rpL3-c 5‟-
GGGCATTGTGGGCTACGT-3‟ (forward) and 5‟-
GTAAAGGCCTTCTTCTTAG-3‟ (reverse); and β-actin 5‟-
GGCACCACCTTCTACA-3‟ (forward) and 5‟-CAGGAGGACAATGAT-
3‟ (reverse). 
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3 Results 
 
3.1 hnRNP H1 binds specifically intron 3 of rpL3 pre-mRNA 
To identify the cis-acting elements in the intron 3 that participate in 
the regulation of rpL3 pre-mRNA splicing, we used a computational 
analysis to look for hnRNP H1-binding sequence motifs in the intron 3 of 
rpL3 pre-mRNA. The search revealed the presence of seven G-rich 
sequences known as G-run elements that are able to bind the hnRNP H1 
protein. Because of experimental evidence that hnRNP H1 activity in the 
splicing event is mediated by the binding of the protein to G runs, we 
performed REMSA experiments to assess whether the putative binding sites 
are necessary for the interaction of hnRNP H1 with intron 3 in the pre-
mRNA transcript. Intron 3 was divided in three regions:  region A spanning 
365 nt downstream from the 5′ donor splice site containing seven G-run 
elements, region B (289 nt) constituted by the 3′ moiety of intron 3 and 27 
nt of exon 4, and region C (209 nt), a more restricted region encompassing 
the seven G runs (Fig. 3.1A). These regions were transcribed in vitro with 
32
P-NTPs and incubated with recombinant protein GST-hnRNP H1 or GST.  
The resulting RNA–protein complexes were analyzed on a native 
polyacrylamide gel and the results visualized by autoradiography. As shown 
in the figure, GST-hnRNP H1 was able to interact specifically with RNA 
transcribed on regions A (Fig. 3.1B) and C (Fig. 3.1C) of intron 3, but failed 
to do so when challenged with the B region transcript (Fig. 3.1B). No 
mobility shift was observed when recombinant GST was challenged with a 
transcript constituted by the three regions of intron 3 (Fig. 3.1B and 3.1C).  
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These results indicate that hnRNP H1 binds in vitro to the region of the 
intron 3 transcript that contains seven G run elements. 
 
 
          
 
 
Figure 3.1 hnRNP H1 binds region A of rpL3 pre-mRNA intron 3. 
(A) schematic representation of the regions A, B and C of intron 3. (B) 
REMSA of hnRNP H1 with regions A and B. (C) Analysis with region C. 
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3.2 hnRNP H1 binds G3 and G6 regulating AS 
To evaluate the role of each G run in the regulation of splicing of rpL3 
pre-mRNA, we produced a series of wt-rpL3 minigene mutants (see 
Napolitano PhD thesis 2010); the results strongly suggest that elements G3 
and G6 are directly involved in the regulation of the splicing of rpL3 
transcript intron 3 (Fig. 3.2A).  
These results together with data from hnRNP H1 silencing (see 
Napolitano PhD thesis 2010)  provide strong evidence that the effects on the 
splicing pattern of rpL3 pre-mRNA could be mediated directly by the 
interaction of hnRNP H1 with G3 and G6 elements. To verify these 
findings, we overexpressed hnRNP H1 in HeLa cells transfected with the 
wt-rpL3 (minigene containing wild type G-run elements) , G[2,3,5,6]*  
(where G-run element number 2, 3, 5 and 6 were mutated in GAT) or 
G[3,6]* (where only G3 and G6 elements were mutated in GAT) minigenes 
under conditions that could lead to a larger than three-fold increase of the 
rpL3-a transcript level. Despite hnRNP H1 overexpression, the splicing 
pattern of the double mutant G[3,6]* showed that the level of alternative 
transcript was 60% lower than the level of the control wt-rpL3 minigene 
(Fig. 3.2B). 
These data indicate that the G3 and G6 elements represent the 
consensus binding motifs of hnRNP H1 and are required for the hnRNP H1-
mediated regulation of rpL3 pre-mRNA splicing. 
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Figure 3.2 hnRNP H1 binds G3 and G6 regulating AS (A) 
Representative RT-PCR of total RNA extracted from CHX-treated HeLa 
cells transfected with the wt-rpL3 minigene or mutated constructs (see 
Napolitano PhD thesis) (B) hnRNP H1-HA was detected by western 
blotting (WB) using antibodies against the HA epitope. Loading in the lanes 
was controlled by detection of tubulin protein (upper panel). Representative 
RT-PCR of total RNA extracted from CHX-treated HeLa cells transfected 
with hnRNP H1-HA or co-transfected with G[2,3,5,6]* or G[3,6]* or the 
wt-rpL3 minigene and hnRNP H1-HA (lower panel). 
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3.3 NPM, KHSRP, hnRNP H1 and rpL3: interaction in vivo and in 
vitro 
As discussed previously, we have identified by a proteomic analysis a 
number of proteins associated to rpL3 and/or to intron 3 transcript of the 
rpL3 gene, and we focused our studies on proteins involved in RNA 
processing as putative components of a RNP complex including rpL3 and 
mediating alternative splicing of the rpL3 pre-mRNA.  
Particularly, we asked whether hnRNP H1, NPM and KHSRP could 
be part of a RNP complex including rpL3 through a direct or indirect 
interaction in vivo, thus we have performed a co-immunoprecipitation 
assays showed in figure 3.3A in which NPM and KHSRP were 
immunoprecipitated with specific antibody from HeLa cells extracts. 
Immunoprecipitated proteins were separated by SDS–PAGE and the 
presence of NPM and KHSRP was investigated by western blotting in the 
reciprocally immunoprecipitated complexes. The results of these 
experiments showed that NPM and KHSRP were coimmunoprecipitated, 
thus indicating that they can associate in vivo. Furthermore, a specific signal 
for rpL3 appeared both in NPM as well as in KHSRP immunocomplexes. 
These data suggest that rpL3 is able to interact in vivo with both 
proteins.  The presence of signal for hnRNP H1 in both immunoprecipitates 
was consistent with a specific association between NPM, KHSRP and 
hnRNP H1. A control immunoprecipitate obtained with anti-IgG antibodies 
did not give any signal, when probed with anti-NPM, anti-KHSRP, anti-
rpL3 or anti-hnRNP H1. 
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In an effort to define a RNP complex including rpL3, we investigated 
protein–protein interactions that rpL3 protein partners may establish within 
the complex. To this aim, we performed GST pull-down assays by using 
purified recombinant proteins. His-tagged proteins were tested for their 
ability to bind to immobilized GST-tagged proteins. GST-tagged proteins, 
and GST as control, were immobilized using GSH-sepharose beads and 
incubated with purified His-tagged proteins. Western blot analysis was 
performed on each pull-down sample. Figure 3.3B shows that His-hnRNP 
H1 was present in the pull-down preparation of GST-NPM, but not in those 
of GST-rpL3 or GST; His-NPM was detected in the pull-down preparations 
of GST-rpL3, GST-hnRNP H1, but not in that of GST; and His-KHSRP was 
revealed in the pull-down preparations of GST-rpL3 and GST-hnRNP H1, 
but not in those of GST-NPM or GST.  
These results indicate that although a direct interaction between rpL3 
and hnRNP H1 has not been observed, rpL3 and hnRNP H1 are able to 
interact directly with NPM and KHSRP, while NPM and KHSRP are not 
able to interact directly in the in vitro assay. 
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Figure 3.3 (A) In vivo binding of NPM, KHSRP, hnRNP H1 and 
rpL3. NPM or KHSRP were specifically immunoprecipitated from HeLa 
cells extracts with antibodies against the endogenous NPM and KHSRP. 
Immunoprecipitates were separated by SDS–PAGE and immunoblotted 
with antibodies versus the indicated proteins. Note the absence of signal in 
IgG immunocomplex. (B) Analysis of the interactions between hnRNP 
H1, NPM, KHSRP and rpL3. Western blotting (WB) of GST pull-down 
experiments. Fifty microgram of GST-tagged proteins (GST-NPM, GST-
rpL3 and GST-hnRNP H1) or GST (control) were immobilized on 
glutathione-sepharose beads and incubated with 20 mg of His-hnRNP H1, 
His-NPM or His-KHSRP. The eluted proteins were then analyzed by 
immunoblot with antibodies anti-hnRNP H1, anti-NPM and anti-KHSRP. 
Note the absence of signal in control GST pull-down preparations. 
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3.4 NPM, KHSRP, hnRNP H1 and intron 3 transcript: interaction 
in vivo and in vitro 
Mass spectral analysis of RNA pull-down experiments shown 
previously (see Introduction, Fig. 1.3), revealed that KHSRP was able to 
interact with intron 3 transcript of rpL3 gene in vitro. To confirm this 
interaction in vivo, we performed RNA affinity immunoprecipitation 
experiments. We specifically immunoprecipitated KHSRP, and hnRNP H1 
as control, from HeLa cell extracts by using monoclonal antibodies against 
the endogenous proteins and searched for the intron 3 transcript in the 
RNA–protein immunoprecipitate complex (Figure 3.4A). Amplification of 
the signal corresponding to the intron 3 of rpL3 transcript, but not of rpL7a 
gene transcript, by RT–PCR indicated that KHSRP was able to bind with 
rpL3 pre-mRNA. The absence of signal in the immunoprecipitate with anti-
IgG confirmed the validity of this assay. Although NPM was not found 
associated to the intron 3 transcript in vitro previously, we wondered 
whether this interaction could occur in vivo. To this aim, we specifically 
immunoprecipitated NPM from HeLa cell extracts by using monoclonal 
antibodies against the endogenous NPM. Analysis of RNA extracted from 
the immunoprecipitate complex demonstrates that NPM is able to 
precipitate the intron 3 transcript (Figure 3.4A).  
Next, in order to establish whether one or more among the identified 
proteins was able to interact directly with intron 3 RNA, or whether 
additional factors were required, we performed RNA pull-down experiments 
by using purified recombinant proteins. For this purpose, a transcript 
corresponding to the entire intron 3 of the rpL3 gene was used as bait and  
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incubated with the purified recombinant proteins His-hnRNP H1 (control), 
His-NPM or His-KHSRP and His-rpL7a as a control RNA binding protein. 
Then, RNA-associated proteins were eluted and analyzed by western 
blotting with antibodies against the endogenous hnRNP H1, NPM, KHSRP 
and rpL7a. The presence of signals specific for NPM and KHSRP indicated 
that these two proteins are able to recognize and bind to sequences in the 
rpL3 intron 3 transcript (Figure 3.4B). 
            
Figure 3.4 Analysis of interaction between intron 3 and NPM, 
KHSRP in vivo and in vitro. (A) RT–PCR analysis, by using primers 
against rpL3 intron 3 transcript and rpL7a RNA transcript, of RNA 
extracted from the NPM, KHSRP, hnRNP H1 (control) and IgG 
immunocomplexes. Note the absence of signal in IgG immunocomplex. (B) 
WB of RNA pull-down experiments, using adipic acid dehydrazide agarose 
beads coated with intron 3 transcript or unrelated RNA (Ctr RNA) incubated 
with purified proteins His-hnRNP H1, His-NPM, His-KHSRP and His-
rpL7a. 
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3.5 KHSRP regulates alternative splicing of rpL3 pre-mRNA 
The identification of a specific interaction of KHSRP with rpL3 and 
intron 3 transcript, prompted us to investigate a possible role of KHSRP in 
the rpL3 gene splicing. To this aim, we analyzed the effects of the alteration 
in the expression levels of KHSRP on the rpL3 RNA splicing pattern.  
We used L3-8 cells, a PC12 Tet-Off cell line stably transfected with a 
vector containing the human rpL3 coding sequence fused to the 
hemagglutinin (HA) epitope coding sequence. L3-8 cells were transiently 
transfected with the DNA construct expressing Flag-KHSRP. We chose a 
dose of Flag-KHSRP that would result in about a 50% increase of the rpL3 
alternative isoform mRNA (see Napolitano PhD thesis 2010). 24 hours after 
transfection, we treated cells with CHX and induced the expression of HA-
rpL3 by removing doxycycline from medium. Cells were then lysed and 
analyzed for the production of Flag-KHSRP and HA-rpL3 by western 
blotting using anti-Flag and anti-HA antibodies, respectively (Fig. 3.5A, left 
panel). Total RNA was analyzed by RT-PCR using specific primers to 
amplify canonical (rpL3-c) or alternative (rpL3-a) isoform of rpL3 mRNA 
(Fig. 3.5A, right panel). The expression of exogenous KHSRP caused an 
increase in rpL3-a mRNA level. Of interest, the increase in the rpL3-a 
mRNA caused by overexpression of KHSRP was greater after the induction 
of HA-rpL3 (Fig. 3.5A, right panel). 
 The effects of KHSRP on rpL3 splicing were also investigated in 
condition of mRNA silencing. L3-8 cells were treated with siRNA specific 
for KHSRP and, 24 hours after transfection, cells were treated with CHX 
and HA-rpL3 production was induced by removing doxycycline from  
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culture medium. Cells were then lysed and protein extracts were analyzed 
for the expression of KHSRP and HA-rpL3 by western blotting using anti-
KHSRP and anti-HA antibodies, respectively. As shown in Figure 3.5B (left 
panel), the decrease of KHSRP level was about 70% compared to the 
protein amount detected in the control lysates. To examine the effects of the 
reduced production of KHSRP on the splicing pattern of rpL3 pre-mRNA, 
we analyzed total RNA extracted from the same samples by RT-PCR using 
specific primers to amplify rpL3-c and rpL3-a mRNAs. As expected, in 
cells overexpressing rpL3, we observed an increased level of rpL3-a mRNA 
isoform. However, in cells in which KHSRP had been silenced, rpL3 
induced overexpression was less effective in promoting the production of 
rpL3-a mRNA isoform (Fig. 3.5B, right panel). 
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Figure 3.5 (A) Effect of KHSRP over expression and (B) Effect of 
RNAi-mediated depletion of KHSRP on rpL3-a mRNA level in L3-8 
cells.  
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3.6 Coupling of hnRNP H1and KHSRP in rpL3 pre-mRNA splicing  
Both hnRNP H1 and KHSRP promote 3‟ cryptic splicing site 
selection of rpL3 pre-mRNA, so we asked whether a cooperation between 
these two proteins would occur, or whether their functions were redundant. 
To clarify this issue, we switched off the expression of the gene encoding 
hnRNP H1 by using RNA interference. To this purpose, siRNAs against 
hnRNP H1 were transiently transfected in L3-8 cells. 24 hours after 
transfection, cells were treated with CHX, induced for HA-rpL3 production 
and harvested; RNA and proteins were extracted. Lysates from cells 
transfected with siRNA or untransfected were probed with hnRNP H1 
antibodies. As shown in Figure 3.6A (left panel), the residual level of 
hnRNP H1 was about 20% of the protein detected in the control lysates. To 
investigate the effects of the reduced production of hnRNP H1 on the 
splicing pattern of rpL3 pre-mRNA, we examined the level of rpL3 mRNA 
isoforms using RT-PCR. Under normal conditions of rpL3 expression, the 
depletion of hnRNP H1 resulted in a relevant decrease (about 80%) of the 
alternative mRNA (rpL3-a) level compared to controls. In conditions of 
hnRNP H1 removal, rpL3, although overexpressed, failed to activate the 
selection of the 3‟ cryptic splicing site (Fig. 3.6A, right panel). These data 
indicate clearly that hnRNP H1 plays a crucial role in triggering the 
alternative splicing reaction of rpL3 pre-mRNA.  
 Next, we investigated a possible involvement of hnRNP H1 in 
KHSRP-mediated activity. To this aim, we analyzed the effects of hnRNP 
H1 depletion and KHSRP overexpression on rpL3 splicing reaction. L3-8 
cells were transiently co-transfected with siRNA specific for hnRNP H1 and  
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a DNA construct expressing Flag-KHSRP. 24 hours after transfection, cells 
were treated with CHX, induced for HA-rpL3 expression, and harvested. 
hnRNP H1 and KHSRP protein levels were detected by western-blotting 
(Fig. 3.6B, left panel). RNA extracted from the same lysates was analyzed 
by RT-PCR. The figure 3.6B (right panel) shows that when hnRNP H1 was 
depleted, the enforced expression of KHSRP did not cause an increase of 
rpL3-a mRNA level, either in normal conditions of rpL3 expression, or in 
rpL3 overproduction. These findings indicate that the ability of KHSRP to 
influence the splicing of rpL3 pre-mRNA is mediated by hnRNP H1. 
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Figure 3.6 (A) Effect of RNAi-mediated depletion of hnRNP H1 
on rpL3-a mRNA level in L3-8 cells. (B) Effect of KHSRP over 
expression in condition of hnRNP H1 silencing on rpL3-a mRNA level 
in L3-8 cells. 
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3.7 NPM regulates alternative splicing of rpL3 pre-mRNA  
To investigate the role of NPM in the context of rpL3 autoregolatory 
loop, we performed experiments of overexpression and RNAi-mediated 
silencing of NPM in L3-8 cell line. Cells were transiently transfected with a 
DNA vector expressing HA-NPM.. 24 hours after transfection, cells were 
treated with CHX and induced to express HA-rpL3. Cells were then lysed 
and analyzed for the production of HA-NPM and HA-rpL3 by western 
blotting by using anti-HA antibody (Fig. 3.7A, left panel). Total RNA from 
the same samples was analyzed by RT-PCR by using specific primers to 
amplify rpL3-c and rpL3-a isoforms of rpL3 mRNA. The overexpression of 
NPM resulted in a reduction in the rpL3-a mRNA amount in normal 
conditions of rpL3 expression, and prevented the increasing of rpL3-a 
mRNA level when rpL3 protein was overexpressed (Fig. 3.7A, right panel).  
To investigate the effects of NPM removal on rpL3 gene splicing, 
NPM expression levels were reduced by transfecting L3-8 cells with 
specific siRNA. 24 hours after transfection, cells were treated with CHX 
and induced to express HA-rpL3. Protein extracts from cells were tested for 
the production of HA-NPM and HA-rpL3 by western blotting (Fig. 3.7B, 
left panel). Total RNA was analyzed by RT-PCR by using specific primers 
to amplify rpL3-c and rpL3-a mRNA isoforms. In normal conditions of 
rpL3 expression, the depletion of NPM did not affect the level of the rpL3-a 
mRNA. Of interest, upon NPM silencing, HA-rpL3 expression caused a 
significant increase of rpL3-a mRNA levels (Fig. 3.7B, right panel). 
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Figure 3.7 Effect on rpL3-a mRNA level in L3-8 cells after NPM 
over expression (A)  or RNAi-mediated depletion (B). 
 
 
Results 
34 
 
 
 
 
 
Discussion 
35 
 
 
4. Discussion 
In eukaryotes, in order to maintain ribosome biosynthesis at the level 
appropriate to growth conditions and requirements of the cell, the 
expression of ribosomal protein is regulated by multiple control 
mechanisms, mostly at post-transcriptional and translational level 
(Cuccurese et al. 2005, Russo A. et al. 2010, Russo A. et al. 2011, Loreni et 
al. 1993); moreover, several studies prove that ribosomal proteins, in 
addition to the role as components of the translation machinery, exert a 
variety of extraribosomal functions, for which additional, specific regulatory 
strategies are required (Wang et al. 2007, Chaudhuri et al. 2007). 
More specifically, in our laboratory was previously demonstrated a 
role of AS-NMD in the regulation of the rpL3 gene expression, promoted by 
rpL3 protein itself as part of an auto-regulatory negative-feedback loop 
(Cuccurese et al. 2005). In order to investigate the molecular mechanism of 
this auto-regulation, were identified several proteins able to bind in vitro 
rpL3, the intron 3 of rpL3 gene, or both (see Introduction, Fig. 1.3), since in 
most cases, the choice of a splicing site is made by a dynamic and complex 
combination of different splicing regulators; also, the function of an 
individual splicing factor may be different depending on interacting partners 
present in the regulatory network. In particular, I reported in this thesis the 
analysis of the role of hnRNP H1, and of two new regulatory proteins, 
identified, KHSRP (K-homology splicing regulatory protein, also known as 
KSRP) and NPM (B23, numatrin or NO38) in the rpL3 auto-regulatory 
loop.  
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REMSA experiments showed that the splicing factor hnRNP H1binds 
rpL3 intron 3, through a region containing seven G-run elements (Fig. 3.1). 
Previous results demonstrated that rpL3 protein, within a RNP 
complex including the constitutive splicing factor hnRNP H1, promotes the 
alternative splicing reaction of its own gene (see Napolitano PhD thesis 
2010) and mutational analysis of the seven G-run elements in rpL3 intron 3 
showed that G3 and G6 affected splicing. In fact, when both elements were 
mutated (G[3,6]*), the level of the alternative mRNA isoform was reduced 
by 80%, while when wild-type G3 and G6 were conserved and all other G 
runs mutated (see G[1,2,4,5,7]* in Fig. 3.2A), the amount of alternative 
rpL3 mRNA isoform was the same as the amount obtained from the wt-
rpL3 primary transcript. Moreover, when G3 and G6 motifs were mutated, 
hnRNP H1 overexpression did not affect the level of the alternatively 
spliced mRNA isoform (Fig. 3.2B). 
These results prove that G3 and G6 form a functional unit, and that its 
interaction with hnRNP H1 promotes the selection of the alternative 3′ 
splice site of intron 3. 
 Thereafter, analysis of immunoprecipitate of NPM and KHSRP in 
HeLa cell extracts showed that NPM and KHSRP coimmunoprecipitate 
together with rpL3 and hnRNP H1, indicating that these proteins associate 
in vivo, although the occurrence of multiple complexes including different 
combination of protein interactions cannot be excluded (Fig. 3.3A). In 
addition, in vitro GST pull-down experiments (Fig. 3.3B) demonstrated that 
NPM and KHSRP are able to recognize and bind rpL3 and hnRNPH1,  
 
Discussion 
37 
 
 
whereas a direct binding between NPM and KHSRP, or rpL3 and hnRNPH1 
has not been observed. 
Likewise, analysis of RNA immunoprecipitation assays showed the 
presence of intron 3 RNA in the immunoprecipitate of NPM and KHSRP 
(Fig. 3.4A), and RNA pull-down experiments showed that NPM and 
KHSRP are able to contact directly the intron 3 RNA (Fig. 3.4B) as 
previously shown for hnRNP H1 by REMSA. Taken together, these data 
strongly suggest that NPM and KHSRP with hnRNP H1 are involved in the 
control of the splicing of rpL3.  
Analysis of the effects of individual expression of NPM, hnRNP H1 
or KHSRP provided an insight also on the specific role of each protein 
factor on the rpL3 gene splicing. In the context of rpL3 autoregulatory 
circuit, protein overexpression data indicated that KHSRP represents a 
positive regulator of the alternative splicing that cooperates with rpL3 and 
hnRNP H1 in the activation of 3‟-cryptic splice site (Fig. 3.5A); instead, 
silencing of KHSRP caused about 20% decrease of the alternative 
mRNA isoform produced when rpL3 is overexpressed, suggesting that 
KHSRP is not a crucial player in the rpL3 autoregulatory loop (Fig. 3.5B). 
Moreover, when hnRNPH1 expression was silenced, rpL3 
overexpression failed to result in the activation of cryptic the 3‟-splice site 
(Fig. 3.6A), and  KHSRP, even in excess, was unable to increase the 
alternative mRNA isoform in the absence of hnRNP H1 (Fig. 3.6B).  
These results strongly indicate that hnRNP H1 is an essential 
component of rpL3 auto-regulatory loop, while KHSRP might play a role as  
 
Discussion 
38 
 
 
an enhancer of hnRNP H1-mediated activation of rpL3 gene alternative 
splicing. 
 It is known that the RNA binding activity of KHSRP is mediated by 
four KH domains. Among these, KH1 and KH3 domains recognize and bind 
specifically a G-rich target (UGGG and GGGU, respectively) (Garcia-
Mayoral et al. 2007). The analysis of the human intron 3 transcript sequence 
showed that G6 motif, an essential element for the splicing regulatory 
activity of hnRNP H1, could represent also a binding site for KH1 or KH3. 
In addition, the UGCAUG element, essential to the binding of 
KHRSP to src-DCS (Downstream Control Sequence), is also present in the 
sequence of intron 3 RNA and it is located close to the hnRNP H1 binding 
site G3 and G6 motifs (Markovtsov et al. 2000). Consequently, it is possible 
to hypothesize that KHSRP might interact with these sequences within 
intron 3 transcript as well as with hnRNP H1 making more stable and 
efficient the association of hnRNP H1with intron 3 RNA. 
Differently, NPM acts as a negative regulatory factor of rpL3 gene 
alternative splicing (Fig. 3.7); thus, based on these data, we propose a 
working model, which overcomes the model proposed previously (Russo A. 
et al. 2010). 
The model predicts the existence of, at least, two complexes whose 
protein composition depends on rpL3 protein levels. When cell functions 
require an efficient production of rpL3, the interaction of NPM with intron 3 
pre-mRNA might affect its secondary structure and mask the binding sites 
of hnRNP H1. At the same time, repression of AS might be enforced by a 
concomitant direct binding of NPM to the positive regulator factor hnRNP  
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H1 (Fig. 4.1A). When rpL3 levels exceed cell requirements for rpL3 
ribosomal as well as extraribosomal functions, the protein could interact 
with NPM; consequently, NPM would be released from the RNP complex 
to which rpL3 could be associated by interacting with KHSRP. The removal 
of NPM, and the rearrangement of the interactions within the RNP complex, 
could make available the enhancer unit G3+G6 within intron 3 transcript 
and, at the same time, the presence of rpL3 in the remodeled complex could 
induce conformational changes that favor the interaction of hnRNP H1 with 
G3+G6. Finally, such complex could promote the activation of the 
alternative mode of splicing reaction (Fig. 4.1B). 
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Figure 4.1:  Schematic representation of proposed rpL3 feedback 
regulation. 
 
 Concluding, AS-NMD may be most relevant to finely modulate 
production of rpL3 available for extraribosomal functions; rpL3 indeed has 
been involved so far in two extraribosomal functions: a) in the splicing 
regulation of its own pre-mRNA and, b) Preliminary results obtained in our 
lab indicate that rpL3 is involved in a regulatory mechanism of p21 
expression independent from p53. 
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By generating mRNA containing a premature termination codon (PTC), alternative splicing (AS) can
quantitatively regulate the expression of genes that are degraded by nonsense-mediated mRNA decay
(NMD). We previously demonstrated that AS-induced retention of part of intron 3 of rpL3 pre-mRNA
produces an mRNA isoform that contains a PTC and is targeted for decay by NMD. We also demonstrated that
overexpression of rpL3 downregulates canonical splicing and upregulates the alternative splicing of its pre-
mRNA. We are currently investigating the molecular mechanism underlying rpL3 autoregulation. Here we
report that the heterogeneous nuclear ribonucleoprotein (hnRNP) H1 is a transacting factor able to interact
in vitro and in vivo with rpL3 and with intron 3 of the rpL3 gene. We investigated the role played by hnRNP
H1 in the regulation of splicing of rpL3 pre-mRNA by manipulating its expression level. Depletion of hnRNP
H1 reduced the level of the PTC-containing mRNA isoform, whereas its overexpression favored the selection
of the cryptic 3′ splice site of intron 3. We also identiﬁed and characterized the cis-acting regulatory
elements involved in hnRNP H1-mediated regulation of splicing. RNA electromobility shift assay
demonstrated that hnRNP H1 speciﬁcally recognizes and binds directly to the intron 3 region that contains
seven copies of G-rich elements. Site-directed mutagenesis analysis and in vivo studies showed that the G3
and G6 elements are required for hnRNP H1-mediated regulation of rpL3 pre-mRNA splicing. We propose a
working model in which rpL3 recruits hnRNP H1 and, through cooperation with other splicing factors,
promotes selection of the alternative splice site.
©2010 Elsevier B.V. All rights reserved.
1. Introduction
Alternative splicing (AS) is one of themain regulatorymechanisms
of gene expression; it results in a repertoire of mRNAs, and con-
sequently of proteins, much larger than expected from the number of
genes. This process contributes substantially to cell-speciﬁc and
tissue-speciﬁc gene expression; it is estimated that over 60% of human
genes are alternatively spliced [1].
Splicing is modulated by cis elements in intron or exon sequences
that, associated with speciﬁc transacting factors, can negatively
(intronic or exonic splicing silencer sequences, ISS or ESS) or
positively (intronic or exonic splicing enhancing sequences, ISE or
ESE) affect splicing [2]. Although ESE elements differ in sequence,
most share a consensus sequence (GAR)n. The UGCAUG esanucleotide
is a frequent element in ISE sequences [3]. Most regulatory sequences
are a complex combination of multiple elements that mediate positive
or negative effects on gene splicing [4–6]. Intronic stretches of three or
four Gs called “G runs” are involved in the splicing of a number of
genes [7–13].
Among the factors found to control the selection of the splice site,
components of the SR protein family have been shown to antagonize
the activity of protein components of heterogeneous nuclear
ribonucleoproteins (hnRNPs) [14,15]. hnRNPs are a large group of
nuclear RNA-binding proteins that share a common structural domain
denoted “qRRM” and are implicated in a variety of processes including
RNA stability and translation. Accumulating evidence indicates that
these proteins may play an important role in the control of splice site
selection [16,17]. hnRNP H1 is a member of the hnRNPH/F family. It is
able to bind the splicing regulatory cis elements, i.e. ESE, ISE, ESS and
ISS. Depending on the interacting cis element and on the gene context,
hnRNP H1 can affect the selection of the splice site and consequently
promote either constitutive or alternative splicing [9–13,18].
Data from several laboratories demonstrate that some evolution-
arily conserved AS events give rise to aberrant transcripts, which are
substrate of nonsense-mediated mRNA decay (NMD). NMD is an RNA
Biochimica et Biophysica Acta 1799 (2010) 419–428
Abbreviations: AS, alternative splicing; hnRNP, heterogeneous nuclear ribonucleo-
protein; NMD, nonsense-mediated mRNA decay; PTC, premature termination codon;
r-protein, ribosomal protein; rp, ribosomal protein; rp-mRNA, mRNA for ribosomal
protein; RT-PCR, reverse transcriptase-PCR; SH-PTP1, SH-protein-tyrosine phosphatase 1;
siRNA, small interfering RNA; SR, serine-rich
⁎ Corresponding authors. G. Russo is to be contacted at tel.: +39 0817463061;
fax: +39 0817463074. C. Pietropaolo, tel.: +39 0817463065; fax: +39 0817463074.
E-mail addresses: pietropaolo@dbbm.unina.it (C. Pietropaolo),
russog@dbbm.unina.it (G. Russo).
1874-9399/$ – see front matter ©2010 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbagrm.2010.01.008
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbagrm
surveillance mechanism that selectively degrades aberrant mRNAs
that contain a premature termination codon (PTC), thus preventing
the production of truncated polypeptides potentially deleterious to
the cell. This process is highly conserved in eukaryotes. A PTC may
arise through a nonsense or frameshift mutation of DNA, as a con-
sequence of DNA rearrangement, or through splicing errors that
produce aberrant mRNAs [19]. A PTC could also arise from alternative
splicing that produces an intron-derived nonsense codon or a shift in
the ORF that generates a downstream nonsense codon. The resulting
aberrant mRNA is targeted for NMD rather than being translated into
protein. Thus, the AS–NMD association results in quantitative post-
transcriptional regulation of gene expression [20].
Genes that encode ribosomal proteins (rp) are regulated by AS–
NMD. This regulatory strategy appears to be evolutionarily conserved
in nematodes [21] andmammals [22]. We recently demonstrated that
AS of genes for human proteins rpL3 and rpL12 generates alternative
RNA isoforms consequent to the removal of part of intron 3 and of
intron 1, respectively. The resultingmRNAs include intronic sequences
that contain a PTC and are targeted for decay by NMD. We also
demonstrated that overexpression of rpL3 results in the down-
regulation of canonical splicing and upregulation of the alternative
splicing of rpL3 pre-mRNA [22]. Here we report that hnRNP H1 is an
rpL3 partner and plays an important role in the splicing regulation of
rpL3 pre-mRNA. We also report that G-rich sequences in intron 3 are
cis-regulatory elements involved in hnRNP H1-mediated regulation.
2. Materials and methods
2.1. Cell cultures, transfections and drug treatment
Human cell lines HeLa and Calu6 were cultured in Dulbecco's
ModiﬁedEagle'sMedium(DMEM)withglutamax (Invitrogen, Carlsbad,
California) supplemented with 10% fetal bovine serum (FBS). In
addition, Calu6 culture medium was supplemented with 0.1 mM non-
essential amino acids (Euroclone, West York, UK). siRNA transfections
were performed in HeLa cells (1×106 cells, 6 mm-well plate) at a
concentration of 150 nM by using Oligofectamine Reagent (Invitrogen)
according to the manufacturer's instructions.
Plasmids were transfected in HeLa cells (2.5×106 cells, 6 mm-well
plate) by using Lipofectamine 2000 (Invitrogen) or Fugene6 (Roche
Applied Science, Mannheim, Germany) according to the manufac-
turer's instructions. 24 h after DNA or siRNA transfections, cells were
treated with 100 μg/ml cycloheximide for 4 h to block NMD. Then,
RNA and proteins were extracted by using the Trizol procedure
(Invitrogen) for RT-PCR analysis and western blot, respectively.
Transfection efﬁciency was assessed by co-transfecting a GFP-
expressing vector and normalizing RNA levels against GFP mRNA
levels (data not shown).
2.2. Constructs, mutagenesis, and RNA interference
The cDNAs of hnRNP H1 and rpL3 were obtained by RT-PCR from
HeLa cells using speciﬁc primers (Table 1) and cloned into the pro-
karyotic expression vector pGEX4T3 (GE Healthcare, Waukesha,
Wisconsin). The cDNA of hnRNP H1 was also cloned into a version
of the eukaryotic expression vector pcDNA4/HisMax C (Invitrogen)
containing the HA epitope. The full intron 3 of rpL3 gene, or regions A,
B and C (Fig. 3A) were obtained by RT-PCR using speciﬁc primers
(Table 1) and cloned into the pGEM-4Z vector (Promega, Madison,
Wisconsin) to obtain constructs pGEM4Z-Int3, pGEM4Z-IntA,
pGEM4Z-IntB and pGEM4Z-IntC, respectively. The wt-rpL3 minigene
was kindly provided by Y. Tang (Dr S. Stamm's laboratory, Institute for
Biochemistry, University of Erlangen—Nurenberg, Germany). It con-
tains the genomic region of the rpL3 gene spanning from exon 3
to exon 5 ﬂanked by insulin exon sequences (Fig. 5A) cloned in
the Exontrap vector (MoBiTec, Gottingen, Germany). The constructs
carrying the disruption of single or multiple G runs, i.e., GGG/GAT
mutation, were obtained by PCR site-directed mutagenesis (primers
in Table 1) using the QuickChange® Lightning Site-Directed Muta-
genesis Kit (Stratagene, La Jolla, California) and the wt-rpL3 minigene
as template. All constructs were veriﬁed by DNA sequencing.
The small interfering RNAs (siRNA) targeting hnRNP H1 were:
5′-GGAAATAGCTGAAAAGGCT-3′ and 5′-CCACGAAAGCTTATGGCCA-3′.
The siRNA and the Silencer® Negative Control #1 siRNAwere purchased
from Ambion (Foster City, California).
2.3. Nuclear extracts
Nuclear extracts were prepared from Calu6 cells. Brieﬂy, cells from
twenty-one 100-mm plates (1.4×108 cells) were washed with ice
cold PBS and collected in 7 ml of lysis buffer containing 20 mM
Hepes–KOH, pH 8.0, 5 mM MgCl2, 25 mM KCl, 0.5% NP40, 0.25%
sodium-deoxycholate, 5 mM DTT and Protease Inhibitor Mix 1X
(Roche), and passed through a needle (23 gauge). The cell lysate was
incubated for 10 min on ice, then cell nuclei were separated from the
cytoplasmic fraction by centrifugation for 5 min at 1000 ×g at 4 °C.
Nuclei from twenty-one 100-mm plates were resuspended in 2 ml of
nuclear lysis buffer (20 mM Hepes–KOH, 5 mM MgCl2, 0.5 M NaCl,
20% glicerol, 1 mM EDTA, 5 mM DTT and Protease Inhibitor Mix 1X)
and incubated for 10 min on ice, then clariﬁed by centrifugation for
10 min at 10,000 ×g at 4 °C.
2.4. GST pull-down, mass spectrometry and protein identiﬁcation
The recombinant proteins GST-rpL3 and GST were expressed in
Escherichia coli and puriﬁed by using glutathione-Sepharose 4B beads
according to the manufacturer's instructions (GE Healthcare). For GST
pull-down assay, 100 µg of GST-rpL3 fusion protein, or GST control,
was immobilized on glutathione-Sepharose beads and incubated with
10 mg of nuclear extract from Calu6 cells in pull-down buffer (50 mM
Tris–HCl pH 7.5, 0.4 mM EDTA, 150 mM NaCl, 10% glicerol, 1% NP40,
1 mM sodium–ortovanadate, 50 mM NaF, 5 mM DTT and Protease
Inhibitor Mix 1X) at 4 °C for 1.5 h. The beads were washed extensively
and boiled in SDS sample buffer. The eluted proteins were loaded on
12% SDS-PAGE. Gels were stained with a colloidal blue staining kit
(Invitrogen) and protein bands were excised from the gel and
destained by repetitive washes with 0.1 M NH4HCO3, pH 7.5 and
acetonitrile. Samples were reduced by incubationwith 50 µl of 10 mM
DTT in 0.1 M NH4HCO3 buffer, pH 7.5 and carboxyamidomethylated
with 50 µl of 55 mM iodoacetamide in the same buffer. Enzymatic
digestion was carried out with trypsin (12.5 ng/µl) in 10 mM am-
monium bicarbonate, pH 7.8. Gel pieces were incubated at 4 °C for 2 h.
Trypsin solution was then removed and a new aliquot of the digestion
solution was added; samples were incubated for 18 h at 37 °C. A
minimum reaction volume was used to obtain complete rehydration
of the gel. Peptides were then extracted by washing the gel particles
Table 1
Oligonucleotides sequences.
5′-Primer (5′–3′) 3′-Primer (3′–5′)
GST-rpL3 ATGTCTCACAGAAAGTTC AGCTCCTTCTTCCTTTGC
Int3 AATTGGTAAGGGAGGAG TATGCCTTCAGGAGCAGA
rpL3-a CTCCGCTGGGCTCTGCCC CTTCAGGAGCAGAGCAGA
rpL3-c GGGCATTGTGGGCTACGT GTAAAGGCCTTCTTCTTAG
IntA AAGAATTGGTAAGGGAGG GGAAGCCCACTCAGTGAT
IntB CCAGGGCAAAAGGTTTG GTAAAGGCCTTCTTCTTAG
IntC AAGAATTGGTAAGGGAGG TCAGAATGAGGGTGTTAGC
GST-hnRNP H1 ATGATGTTGGGCACGGAA CTATGCAATGTTTGATTG
hnRNP H1-HA ATGATGTTGGGCACGGAA CTATGCAATGTTTGATTG
β-Actin GGCACCACCTTCTACA CAGGAGGACAATGAT
Insulin GCGAAGTGGAGGACCCACAA ACCCAGCTCCAGTTGTGCCA
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with 10 mM ammonium bicarbonate and 1% formic acid in 50%
acetonitrile at room temperature.
Liquid chromatography and tandem mass spectrometry (LC/MS/
MS) analyses were performed on an LC/MSD Trap XCT Ultra (Agilent
Technologies, Palo Alto, CA) equipped with a 1100 nanoHPLC system
and a chip cube (Agilent Technologies). Peptides were analyzed using
data-dependent acquisition of one MS scan (mass range from 300 to
1800m/z) followed by MS/MS scans of the three most abundant ions
in each MS scan. Raw data from nanoLC/MS/MS analyses were used
to query a non-redundant protein database using in-house MASCOT
software (Matrix Science, Boston, Massachusetts) [23].
2.5. Immunoprecipitation and western blotting
For immunoprecipitation assay, 1 mg of HeLawhole cell lysate was
incubated with 30 µl of protein A/G agarose beads coated with 5 µg of
antibody against rpL3 (Primm Milan, Italy), hnRNP H1 and SH-PTP1
(Santa Cruz Biotechnology, Santa Cruz, California) at 4 °C for 12 h. The
beads were washed and boiled in the SDS sample buffer. The eluted
proteins were loaded on 12% SDS-PAGE and detected by western
blotting. Aliquots of protein samples (30 µg) were resolved by 12%
SDS-gel electrophoresis and transferred into nitrocellulose ﬁlters. The
membranes were blocked in PBS, 0.2% Tween and 5% dry milk for 2 h,
and then challenged with anti-rpL3 (Primm), anti-hnRNP H1, anti-α-
tubulin, anti-SH-PTP1 (Santa Cruz Biotechnology), and anti-HA
(Roche). The proteins were visualized with enhanced chemilumines-
cence detection reagent according to the manufacturer's instructions
(Pierce, Rockford, Illinois).
2.6. RNA pull-down assay
To identify proteins that bind speciﬁcally to the intron 3 transcript,
we carried out an RNA pull-down assay using adipic acid dehydrazide
beads. Brieﬂy, 20 μg of intron 3 RNA, transcribed in vitro from
pGEM4Z-Int3, was placed in a 400 µl reaction mixture containing
100 mM NaOAc, pH 5.2 and 5 mM sodium m-periodate (Sigma, St.
Louis, Missouri), incubated for 1 h in the dark at room temperature,
ethanol-precipitated, and resuspended in 100 μl of 100 mM NaOAc,
pH 5.2. Then 300 μl of adipic acid dehydrazide agarose beads 50%
slurry (Sigma) equilibrated in 100 mM NaOAc, pH 5.2 was added to
this mixture, which was then incubated for 12 h at 4 ° C on a rotator.
The beads with the bound RNA were pelletted, washed twice with
1 ml of 2 MNaCl, and equilibrated in washing buffer (5 mMHepes, pH
7.9, 1 mM MgCl2, and 0.8 mM magnesium acetate). The intron 3 RNA
was then incubated with 6 mg of protein extract from HeLa cells for
30 min at room temperature in a ﬁnal volume of 0.6 ml. Heparin was
also added to a ﬁnal concentration of 7 μg/μl. The beads were then
washed four times in 1.5 ml of washing buffer. Bound proteins were
Fig. 1. In vitro and in vivo binding of hnRNP-H1 to rpL3. (A) In vitro binding of hnRNP H1 to rpL3. Coomassie Blue-stained gel of a GST pull-down experiment. The recombinant GST-
rpL3 proteins and the GST control were incubated with nuclear extracts from Calu6 cells in the presence of glutathione-Sepharose beads. The eluted proteins were resolved by SDS-
PAGE. M indicates themobility of protein size markers. The arrows indicate the bands corresponding to GST-rpL3, hnRNP H1 and GST. The rpL3 partner proteins are listed. (B) In vivo
binding of hnRNP H1 to rpL3. hnRNP H1 or rpL3 were immunoprecipitated from HeLa cells extracts with antibodies against hnRNP H1 and rpL3, respectively. Immunoprecipitates
were separated by SDS-PAGE and immunoblotted for the proteins indicated at the left of the panel. These results are representative of three independently performed experiments.
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eluted in SDS sample buffer and loaded on a 12% gel for SDS-PAGE to
proceed to a MS analysis (see 2.4).
2.7. RNP immunoprecipitation assay (RIPA)
For RNP immunoprecipitation assay, HeLa cells (2×106 cells) were
lysed in 600 μl RIPA buffer 1× (10 mM Tris–HCl, pH 7.5, 150 mMNaCl,
0.1 mM EDTA, 1 mM Na ortovanadate, 0.05 M NaF, and 0.5% NP40)
with protease inhibitors (Roche) for 60 min on ice and then
centrifuged at 10,000 ×g at 4 °C for 15 min. The supernatant was
subjected to a preclearing step in which it was incubated with 50 μl of
protein A/G plus agarose for 1 h at 4 °C. The precleared cell extracts
were then incubated with antibodies speciﬁc for each protein (Santa
Cruz) overnight at 4 °C. Protein G–Sepharose beads (50 μl of 50%
slurry)were then added and themixwas incubated for 1 h at 4 °Cwith
gentle shaking and centrifuged. The immunoprecipitates were
suspended in 100 μl TES buffer (10 mM Tris–HCl, pH 7.5, 0.5 mM
EDTA, and 0.5% SDS), incubated at 65 °C for 10 min and centrifuged for
1 min at 10,000 ×g. Tenmicroliters was stored as immunoprecipitated
samples and subsequently fractionated by SDS-PAGE to be analyzed by
western blotting. RNA was extracted from 90 μl using the Trizol
(Invitrogen) procedure.
2.8. RNA electromobility shift assay (REMSA)
RNA probes were transcribed in vitro using 32P-NTPs and SP6
polymerase according to themanufacturer's instructions (Roche), and
construct pGEM4Z-IntA, pGEM4Z-IntB, or PGEM4Z-IntC as template.
The probes were puriﬁed using Sephadex G-25 columns (Roche).
5×105 counts/min of each RNA probe were incubated in binding
buffer containing 20 mM Hepes, pH 7.9, 150 mM KCl, 1.5 mM MgCl2,
0.2 mM EDTA, 0.1% Triton, 1 mg/ml tRNA, and 0.4 U/μl RNase
Inhibitor (Roche) in the presence or absence of the recombinant
protein GST-hnRNP H1 or GST for 1 h at 4 °C. The complexes formed
were then resolved onto a 5% polyacrylamide (37.5:1 acrylamide:bis-
acrylamide ratio) RNA native gel. The gel was dried at 80 °C for 30 min
and the results visualized by autoradiography.
Fig. 2. Interaction of intron 3 of the rpL3 gene with hnRNP H1 in vitro and in vivo. (A) In vitro binding of the intron 3 transcript to hnRNP H1. Coomassie Blue-stained gel of a RNA
pull-down experiment, using adipic acid dehydrazide agarose beads coated with intron 3 transcript was incubated with HeLa nuclear protein extract. The mobility of protein size
markers is shown (M). The arrow indicates the protein band corresponding to hnRNP H1 identiﬁed by mass spectrometry analysis of eluted peptides. The intron 3 RNA interacting
proteins identiﬁed are listed. (B) In vivo binding of the intron 3 transcript to hnRNP H1.Western blotting (WB) of hnRNP H1 or SH-PTP1 immunoprecipitates fromHeLa cells, and RT-
PCR of RNA extracted from the same immunoprecipitates by using primers against intron 3 (Table1). Note the absence of signal in SH-PTP1 immuno-complex. These results are
representative of three independently performed experiments.
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2.9. RT-PCR
For RT-PCR analysis, 1 μg of total RNAwas reverse-transcribed into
cDNA with the random hexamer technique using 200U of Superscript
II RNase H− Reverse Trancriptase (Invitrogen). The reaction was
carried out at 42 °C for 50 min and was terminated by heating to 75 °C
for 15 min. Ten of the 40 μl of reaction mix were PCR-ampliﬁed in a
ﬁnal volume of 50 μl, using 5 μM of each speciﬁc primer (Table 1),
10 mM dNTPs, and 0.5U of Taq DNA polymerase (Invitrogen).
Typically, 25–30 cycles of ampliﬁcation were performed. In separate
experiments, we ascertained that the cycle number was within the
linear range of ampliﬁcations. PCR products were visualized on 1%
agarose gel containing the ﬂuorescent Vistra Green dye (Amersham
Pharmacia Biotech). The labeling intensity of the PCR product, which
is linear to the amount of DNA, was quantiﬁed using the Phosphor-
Imager (Bio-Rad, Haercules, California).
3. Results
3.1. rpL3 interacts with hnRNP H1 in vitro and in vivo
An important issue concerning the autoregulation of rpL3 ex-
pression via AS–NMD coupling is to identify molecular partners of
rpL3 involved in the splicing event. We previously found that rpL3
does not bind its pre-mRNA. Speciﬁcally, ﬁlter-binding experiments
with the recombinant GST-rpL3 and GST alone as control showed that
rpL3 could interact with intron 3 RNA as well as with unrelated RNA
(data not shown). These ﬁndings favored the hypothesis that rpL3
modulates the splicing of its own gene by interacting with one or
more regulatory proteins. Consequently, to search for rpL3 transacting
factors, we carried out an in vitro GST pull-down assay. Recombinant
GST-rpL3 and GST proteins were puriﬁed from E. coli cells, im-
mobilized using GSH-Sepharose beads and incubated with a nuclear
extract from Calu6 cells. The proteins speciﬁcally bound to GST-rpL3
and GST were pulled down, fractionated by SDS-PAGE and then
visualized by Coomassie Blue staining.
The whole gel was cut in slices and protein bands, destained by
repetitive washings, were excised and in situ-digested with trypsin.
We also analyzed the control (proteins bound to GST) to check for
nonspeciﬁc proteins. The resulting peptide mixtures were extracted
from the gel and directly analyzed by LC/MS/MS to obtain sequence
information on individual peptides. This information together with
the peptide mass values was then used to search protein databases for
corresponding proteins. The comparison of GST-rpL3 beads versus
control GST beads revealed several speciﬁc proteins. Among these,
sequence analysis by MS of an excised 50-kDa band yielded several
peptides amongwhich is hnRNP H1 (Fig. 1A). hnRNP H1 plays a major
role in the regulation of alternative splicing of various genes. Recent
studies showed that hnRNP H1 is able to bind speciﬁcally G runs on a
transcript molecule [9–13,18].
To verify the interaction between rpL3 and hnRNP H1 in vivo, we
performed co-immunoprecipitation experiments. hnRNP H1 (Fig. 1B,
Fig. 3. hnRNP H1 binding to region A within intron 3 in vitro. (A) Schematic representation of regions A (365 nt), B (289 nt) and C (209 nt) of intron 3. The sequence of part of the
region C of intron 3 including the G-run motifs is shown (boldface). (B) Gel mobility shift analysis of hnRNP H1 challenged with regions A, and B of intron 3 (left panel), or with
region C of intron 3 (right panel). The results are representative of three independently performed experiments.
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left panel) and rpL3 (Fig. 1B, right panel) were speciﬁcally immuno-
precipitated from HeLa cell extracts and the immunoprecipitated
complexes were tested by western blotting. A signal for both proteins
appeared in immuno-complexes probed with antibodies against rpL3
and hnRNP H1, thus conﬁrming that the two proteins speciﬁcally
interact in vivo (Fig. 1B). A control immunoprecipitate obtained with
an arbitrary antibody, anti-SH-PTP1, did not give any signal when
probed with anti-hnRNP H1 or anti-rpL3 (Fig. 1B).
3.2. hnRNP H1 binds to the intron 3 of the rpL3 gene transcript in vitro
and in vivo
We next performed an in vitro RNA pull-down assay to identify
and isolate the RNA-binding proteins taking part in the alternative
splicing event and, speciﬁcally, to determine whether hnRNP H1 was
able to interact not only with rpL3 but also with its pre-mRNA. A
transcript corresponding to the entire intron 3 of rpL3 pre-mRNA was
used as bait for pull-down interacting proteins. The beads coated with
the intron 3 transcript were incubated with a total protein extract
from HeLa cells. After stringent washing, RNA-associated proteins
were eluted and analyzed by SDS-PAGE. The comparison of the
proteins bound to the intron 3 RNA-coated beads versus control beads
with no RNA showed various speciﬁc bands (Fig. 2A). Each protein
slice was cut and in situ-digested as previously described. Mass
spectral analysis of the protein mixtures revealed several proteins
among which is hnRNP H1.
To evaluate whether intron 3 and hnRNP H1 speciﬁcally interacted
in vivo, we immunoprecipitated hnRNP H1 from HeLa cell extracts
and looked for the intron 3 transcript and rpL3 in the RNA–protein
immunoprecipitate complex (Fig. 2B). The speciﬁc primers, used in
the RT-PCR to detect the intron 3 transcript were 18-mer oligonucleo-
tides mapping 5 nt upstream from the 5′ splice donor site and 5 nt
downstream from the 3′ splice acceptor site (Int3 in Table 1).We used
western blot and anti-rpL3 antibodies to detect rpL3 in the immuno-
complex. Ampliﬁcation of the signal corresponding to the intron 3
transcript indicated that hnRNP H1 was able to bind rpL3 pre-mRNA
in vivo. Moreover, the co-presence of rpL3 in the immuno-complex
suggests that rpL3 pre-mRNA is present in a ribonucleoprotein
complex that includes rpL3 and hnRNP H1, although the possibility
of two independent complexes cannot be ruled out. The absence of
Fig. 4. (A) Effects of RNAi-mediated depletion of hnRNP H1 on rpL3-a mRNA levels. Left panel: protein samples from CHX-treated HeLa cells transfected with hnRNP H1-siRNA
(hnRNP H1), with unrelated siRNA (control) or untransfected (−), were analyzed by western blotting (WB) with antibody speciﬁc for endogenous hnRNP H1. Loading in the gel
lanes was controlled by detection of tubulin protein. Right panel: representative RT-PCR analysis of total RNA from the same samples. β-actin was used as a control of RNA loading.
Quantiﬁcation of hnRNP H1 protein and of the level of rpL3-a mRNA by PhosphorImager (Bio-Rad) is shown. (B) Effects of hnRNP H1 overexpression on rpL3-a mRNA levels. Left
panel: protein overexpression detected with an antibody directed against the HA tag. Right panel: representative RT-PCR analysis of total RNA from CHX-treated HeLa cells
untransfected or transfected with increasing amounts of hnRNP H1-HA. Quantiﬁcation of hnRNP H1-HA protein and of the level of rpL3-a mRNA by PhosphorImager (Bio-Rad) is
shown. These results are representative of three independently performed experiments.
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signal in the immunoprecipitate with anti-SH-PTP1 conﬁrmed the
validity of this assay (Fig. 2B).
3.3. hnRNP H1 binds selectively to 5′ portion of intron 3
To identify the cis-acting elements of intron 3 that participate in the
regulation of rpL3 pre-mRNAsplicing, we used a computational analysis
of this region to look for hnRNPH1-binding sequencemotifs. The search
revealed seven G-rich motifs that could be hnRNP H1-binding sites in
the 5′moiety on intron 3. Because of experimental evidence that hnRNP
H1activity in the splicingevent ismediatedby thebindingof theprotein
to G runs, we performed REMSA experiments to assess whether the
putative binding sites are necessary for the interaction of hnRNP H1
with intron 3 in the pre-mRNA transcript. We evaluated the hnRNP H1
bindingof three intron3 regions: regionA spanning365 ntdownstream
from the 5′ splice donor splice site containing seven G-run elements;
region B (289 nt) constituted by the 3′ moiety of intron 3 and 27 nt of
exon 4; and region C (209 nt), a more restricted region encompassing
the seven G runs (Fig. 3A). The three regions were transcribed in vitro
using 32P-NTPs. The RNA probeswere incubatedwith GST-hnRNPH1 or
GST recombinant protein. The resulting RNA–protein complexes were
analyzed on a native polyacrylamide gel and the results visualized by
autoradiography.
As shown in Fig. 3, GST-hnRNP H1 was able to interact speciﬁcally
with RNA transcribed on regions A (Fig. 3B, left panel) and C (Fig. 3B,
right panel) of intron 3, but failed to do so when challengedwith the B
region transcript (Fig. 3B). No mobility shift was observed when
recombinant GST was challenged with a transcript constituted by the
three regions of intron 3 (Fig. 3B). These results indicate that hnRNP
H1 binds in vitro to the region of the intron 3 transcript that contains
seven G runs.
3.4. hnRNP H1 regulates the alternative splicing of rpL3 pre-mRNA
To determine the role played by hnRNP H1 in the alternative
splicing of rpL3 primary transcript, we evaluated the effects of altered
hnRNP H1 expression on the selection of the alternative 3′ acceptor
splice site in intron 3 of the rpL3 gene. To this aimwe switched-off the
expression of the gene encoding hnRNPH1 by using RNA interference.
siRNAs against hnRNP H1 or unrelated siRNAs were transiently
transfected in HeLa cells. After transfection, cells were treated with
CHX to stabilize the otherwise labile alternative splice form, and
harvested; then RNA and protein were extracted. Lysates from cells
transfected with unrelated siRNAs (control), speciﬁc siRNAs (hnRNP
H1), or untransfected were probed with hnRNP H1 antibodies. As
shown in Fig. 4A, the residual level of hnRNP H1 was about 30% of the
protein detected in the control lysates. To examine the effects of the
impaired production of hnRNP H1 on the splicing pattern of rpL3 pre-
mRNA, we examined the rpL3 mRNA isoforms using RT-PCR. Removal
of hnRNP H1 resulted in a decrease (about 70%) of the alternative
mRNA (rpL3-a) level compared to controls.
To investigate the effects of hnRNP H1 overexpression we fused a
cDNA encoding hnRNP H1 to an HA tag in the expression vector
pcDNA3. Increasing amounts of this construct were transiently
transfected in HeLa cells. 24 h after transfection, the production of
hnRNP H1 was measured by western blotting (Fig. 4B). Total RNA was
Fig. 5. (A) Schematic representation of wt-rpL3 minigene. The canonic acceptor site AG and the alternative acceptor site AG′ are indicated in boldface. The score of acceptor splice
sites calculated using the Splice Site Prediction by Neural Network program (SSPNN, http://www.fruitﬂy.org/seq_tools/splice.html) is indicated. (B) Scheme of G-run mutants. The
G runs within rpL3 intron 3 are numbered 1 to 7, and the G-run mutants are indicated by ⁎.
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analyzed by RT-PCR by using speciﬁc primers (Table 1) to amplify
canonical (rpL3-c) or alternative (rpL3-a) isoforms of rpL3 mRNA.
Overexpressionof hnRNPH1caused adose-dependent increase in rpL3-
a mRNA level (Fig. 4B).
3.5. G runs are involved in the control of 3′ splice site selection within
rpL3 intron 3
To investigate whether guanosine stretches within intron 3 play a
role in the control of splicing, we exploited a minigene containing a
genomic region spanning from exon 3 to exon 5 (Fig. 5A, wt-rpL3
minigene) of the rpL3 gene. Using site-directed mutagenesis we
changed GGG to GAT in all the G-run elements (G[1–7]⁎ in Fig. 5B).
After transfection of the constructs in HeLa cells, we carried out an RT-
PCR analysis to determine the splicing pattern of the corresponding
transcripts. Speciﬁc primers, designed on the insulin gene sequences
ﬂanking rpL3 gene sequences, were used to discriminate theminigene
splicing products from the products derived from the endogenous
gene (Table 1). As shown in Fig. 6A, the wt-rpL3 minigene reproduced
the splicing pattern of the endogenous gene and hence it contained
the information necessary for correct rpL3 splicing. Differently, pre-
mRNA processing was greatly impaired in the G[1–7]⁎mutant, with a
consequent decrease in the level of the alternative isoform of rpL3
mRNA to 20% versus the control wt-rpL3 minigene. These results
show that the guanosine-rich elementswithin intron 3 are involved in
the control of the 3′ splice site selection in rpL3 intron 3.
3.6. Functional mapping of the G motifs within intron 3
To evaluate the role of each G run in the regulation of the splicing
of rpL3 pre-mRNA, we produced a series of wt-rpL3 minigene
mutants. Mutation of elements G1, G2 and G3 (G[1–3]⁎ in Fig. 5B)
reduced the level of rpL3-a mRNA by 50% (Fig. 6A). The same result
was obtained with mutants G[2,3]⁎ and G[3]⁎. Consequently, the
alteration of the splicing pattern in these mutants can be ascribed
solely to disruption of the G3 element. Differently, the splicing pattern
of the G[7]⁎ mutant (Fig. 5B) shows that mutation of a single G run
does not alter the level of rpL3-a mRNA. In another set of mutants, we
evaluated the role of elements G3, G4, G5 and G6 in the splicing
modulation of rpL3 intron 3. Mutants G[2,3,5]⁎ and G[2–5]⁎ yielded
levels of rpL3-a mRNA similar to that of the G[2,3]⁎minigene mutant.
On the contrary, the addition of themutated G6 element in G[2,3,5,6]⁎
reduced the splicing of rpL3-a mRNA to 20% of that of the control, as
observed with mutant G[1–7]⁎ (Fig. 6A). The results reported above
strongly suggest that elements G3 and G6 are directly involved in the
regulation of the splicing of rpL3 transcript intron 3.
To verify the role of G3 andG6 elements,we generated and analyzed
another set of minigenes (see Fig. 5B): one with a mutation of element
G6 (G[6]⁎), onewithmutation of elements G3 andG6(G[3,6]⁎), and one
Fig. 6. (A and B) Functional mapping of the G-run elements within intron 3. Representative RT-PCR of total RNA extracted from CHX-treated HeLa cells transfected with the wt-rpL3
minigene or mutated constructs (Fig. 5) by using oligonucleotides that amplify minigene products (Table 1). β-actin was used as a control of RNA loading. Quantiﬁcation of rpL3-a
mRNA level using PhosphorImager (Bio-Rad) is shown.
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with mutation of all G runs except elements G3 and G6 (G[1,2,4,5,7]⁎).
Mutation of element G6 alone resulted in a splicing pattern inwhich the
rpL3-a mRNA isoform was about 45% that of the control. A stronger
effect (80% reduction of the rpL3-a mRNA isoform)was observed in the
splicing pattern of the double mutant G[3,6]⁎ (Fig. 6B); the level of the
rpL3-a mRNA isoform was similar to the level obtained with mutant G
[2,3,5,6]⁎ or G[1–7]⁎ (Fig. 6A). Thus, the G3 and G6 elements cooperate
to control the selection of the alternative 3′ splice site in intron 3. Finally,
mutant G[1,2,4,5,7]⁎ (see Fig. 5B) had the same splicing pattern as the
endogenous gene (Fig. 6B), thereby conﬁrming that elements G3 andG6
play a relevant role in the selection of splicingmodality of the rpL3 gene.
These data demonstrate that the G3 and G6 motifs cooperatively
drive the recognition of the alternative 3′ splice site in intron 3,
thereby leading to the inclusion of part of intron 3 in the rpL3-a
mRNA. Furthermore, these results together with data from hnRNP H1
silencing provide strong evidence that the effects on the splicing
pattern of rpL3 pre-mRNA could be mediated directly by the
interaction of hnRNP H1 with G3 and G6 elements. To verify these
ﬁndings, we overexpressed hnRNP H1 in HeLa cells transfected with
the wt-rpL3, G[2,3,5,6]⁎ or G[3,6]⁎ minigenes under conditions that
could lead to a larger than three-fold increase of the rpL3-a transcript
level. Despite hnRNP H1 overexpression, the splicing pattern of the
double mutant G[3,6]⁎ showed that the level of alternative transcript
was 60% lower than the level of the control wt-rpL3 minigene (Fig. 7).
These data indicate that the G3 and G6 elements represent the
consensus bindingmotifs of hnRNPH1 and are required for the hnRNP
H1-mediated regulation of rpL3 pre-mRNA splicing.
4. Discussion
Ribosome biosynthesis requires the coordinated expression of the
genes coding for the structural components, rRNA and r-proteins [24].
To maintain ribosome synthesis at the appropriate level, r-protein
expression is regulated by multiple control mechanisms mostly at
post-transcriptional and translational level. Moreover, r-proteins also
exert a variety of extra-ribosomal functions for which additional and
speciﬁc regulatory strategies are required [25–29]. In eukaryotes,
several post-transcriptional regulation mechanisms have been de-
scribed that control the level of rp-mRNA in the cell by modulating
transcript processing, splicing, and stability. Autoregulation mechan-
isms appear to be a strategy by which each individual r-protein may
control the level of its own expression [21,22,30–32].
We previously demonstrated that, as a consequence of a partial
retention of intronic sequences, splicing of the human rpL3 transcript
gives rise to a canonical mRNA and to an alternative mRNA isoform
containing a PTC that is targeted to NMD. Moreover, our ﬁnding that
rpL3 overexpression downregulates the level of the canonically spliced
mRNA, and upregulates the production of the alternatively spliced
isoform demonstrated that production of human rpL3 is regulated via
a negative feedback loop [22]. Coupling of AS and NMD appears to be a
tool by which to ﬁne tune ribosomal protein levels. However, the
molecular mechanism through which the process occurs is unknown.
In an attempt to shed light on this mechanism we looked for
molecular partners of rpL3, and identiﬁed a number of proteins able to
bind in vitro rpL3, the intron 3 of rpL3 gene, or both (Figs. 1 and 2). In
vivo experiments conﬁrmed that the splicing factor hnRNP H1 could
bind rpL3 as well as its pre-mRNA, and REMSA experiments showed
that this interaction occurs through a pre-mRNA region containing
seven G-run elements (Fig. 3). In addition, depletion of hnRNP H1 by
siRNA resulted in a signiﬁcant reduction of alternative splicing of rpL3
pre-mRNA (Fig. 4A), whereas its overexpression resulted in increased
production of the aberrant rpL3 mRNA (Fig. 4B), which indicates that
hnRNP H1 overexpression was associated with a more efﬁcient usage
of the alternative 3′ acceptor site in intron 3.
G-run motifs are found preferentially in intronic sequences ﬂanking
a splicing site andappear to affect the recognition of anadjacent5′ splice
site or 3′ splice site of the intron. However, they can also functionwhen
located in exons [33].
Mutational analysis of the seven G-run elements in rpL3 intron 3
showed that G3 and G6 affected splicing (see Figs. 5B and 6). In fact,
when both elements were mutated (G[3,6]⁎ in Figs. 5B and 6B), the
level of the alternativemRNA isoformwas reduced by 80%, as occurred
when all G-runmotifs weremutated.Whenwild-type G3 andG6were
conserved and all other G runs mutated (see G[1,2,4,5,7]⁎ in Figs. 5B
and6B), the amount of alternative rpL3mRNA isoformwas the same as
the amount obtained from the wt-rpL3 primary transcript. Moreover,
when G3 and G6 motifs were mutated, hnRNP H1 overexpression did
not affect the level of the alternatively spliced mRNA isoform (Fig. 7).
Given these results we concluded that G3 and G6 form a functional
unit, and that its interaction with hnRNP H1 promotes the selection of
a weak alternative 3′ splice site of intron 3. Cooperation between
different G-richmotifs has beenwidely documented.More copiesmay
increase the afﬁnity of an associated factor and/or recruit more copies
of an interacting factor [33]. For instance, multiple intronic G motifs
regulate the splicing of the thrombopoietin gene through a complex
combinatorial mechanism [11].
The molecular mechanism by which hnRNP H1 regulates AS of the
rpL3 transcript remains to be clariﬁed. Using proteomic analysis, we
identiﬁed several proteins that interacted in vitro with rpL3 and with
the pre-mRNA of the rpL3 gene (Figs. 1A and 2A). It is plausible that
more complex protein–protein interactions between RNA-binding
proteins, hnRNP H1 and rpL3 are involved in the regulation of rpL3
gene splicing. In this context, our results are consistent with a model
in which the rpL3 protein directs the splicing reaction towards the
alternative mode by speciﬁcally interacting with hnRNP H1 (Fig. 8).
In a splicing process leading to the exclusion of exon IIIC of the
FGR2 gene, Fox2 recruits silencing factors and assists hnRNP H1 in
binding an exonic splicing silencer thereby resulting in exon exclusion
[34]. Regarding the rpL3 gene, the process may serve to prevent
wasteful production of the protein. Binding to rpL3 could cause
conformational changes in hnRNP H1 that favor interaction with the
Fig. 7. hnRNP H1 regulates rpL3 pre-mRNA alternative splicing by binding to G3 and G6
elements. (A) hnRNP H1-HA was detected by western blotting (WB) using antibodies
against the HA epitope. Loading in the lanes was controlled by detection of tubulin
protein. (B) Representative RT-PCR of total RNA extracted from CHX-treated HeLa
cells transfected with hnRNP H1-HA (4 μg, control) or co-transfected with G[2,3,5,6]⁎ or
G[3,6]⁎ or the wt-rpL3 minigene (Fig. 5) and hnRNP H1-HA (4 μg). β-actin was used to
control RNA loading. Quantiﬁcation of rpL3-a mRNA level using PhosphorImager (Bio-
Rad) is shown. These results are representative of three independently performed
experiments.
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alternative splicing enhancer unit G3+G6 within intron 3, thereby
allowing correct positioning of the spliceosome, and recruitment of
additional protein factors. Ultimately, such a complex could favor the
selection of the alternative 3′ splice site.
The ongoing analysis of protein components of the RNP complex
involved in the selection of the alternative 3′ splice site will help to
elucidate the ﬁne autoregulatory network of rpL3 expression.
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ABSTRACT
Alternative pre-mRNA splicing (AS) is a major mech-
anism that allows proteomic variability in eukaryotic
cells. However, many AS events result in mRNAs
containing a premature termination codon, which
are degraded by nonsense-mediated mRNA decay
(NMD) pathway. We have previously demonstrated
that human rpL3 autoregulates its expression
through the association of AS with NMD. In fact,
overexpression of rpL3 promotes downregulation
of canonical splicing and upregulation of alternative
splicing that produces an NMD-targeted mRNA
isoform. The result of these events is a decreased
production of rpL3. We have also identified hetero-
geneous nuclear ribonucleoprotein (hnRNP) H1 as a
splicing factor involved in the regulation of rpL3 al-
ternative splicing and identified its regulatory cis-
elements within intron 3 transcript. Here, we report
that NPM and KHSRP are two newly identified
proteins involved in the regulation of rpL3 gene ex-
pression via AS-NMD. We demonstrate that hnRNP
H1, KHSRP and NPM can be found associated, and
present also in ribonucleoproteins (RNPs) including
rpL3 and intron 3 RNA in vivo, and describe protein–
protein and RNA–protein interactions. Moreover, our
data provide an insight on the crucial role of hnRNP
H1 in the regulation of the alternative splicing of the
rpL3 gene.
INTRODUCTION
Alternative splicing (AS) is an important mechanism of
gene expression control, through which an individual
gene gives rise to different mRNAs encoding distinct
proteins, thus allowing functional and genetic variability
(1). In addition to the canonical splice elements, auxiliary
non-splice site RNA sequences have been identiﬁed and
are located in both introns and exons. These additional
elements are needed for a proper splicing and regulation of
the process. They may function as enhancers or silencers
of the splicing reaction, and may inﬂuence recognition
and usage of the splice sites by the splicing apparatus
through the binding of speciﬁc regulatory proteins (2).
These proteins include members of the serine–
arginine-rich (SR) proteins, the heterogeneous nuclear
ribonucleoprotein (hnRNP) family and other RNA
binding proteins (3). The SR proteins represent a family
of highly conserved trans-acting factors that usually
induce splicing, whereas the hnRNP proteins can affect
the splicing depending on the interacting cis-elements
and on the gene context (4,5). Moreover, in some case,
the result of a splicing reaction is determined by the an-
tagonistic action of hnRNP and SR proteins since they are
able to recognize and bind to a composite regulatory
element generated by the overlapping of enhancer and
silencer elements (6).
AS can also control gene expression quantitatively by
generating unproductive mRNAs that are targeted for
degradation by nonsense-mediated decay (NMD) (7).
NMD is a surveillance pathway that detects and selective-
ly degrades aberrant mRNAs harboring a premature ter-
mination codon (PTC), thus preventing the production of
truncated polypeptides potentially deleterious to the cell.
NMD is highly conserved in eukaryotes; many studies
have dissected machinery components, and the issue of
its localization in a cell compartment has been thoroughly
discussed (8,9 and references therein). The process
regulating gene expression through AS-NMD association
has been deﬁned Regulated Unproductive Splicing and
Translation (RUST) (10).
Although the mechanisms of the AS have been exten-
sively studied, the complex regulation of such process is
still an issue. The complexity of the regulation pathways is
due to an intricate and dynamic network of protein–
protein and RNA–protein interactions. Changes in the
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activity, number and association of splicing factors in the
network can modify the selection of the splice site and
the activity of the splicing machinery, and therefore the
splicing pattern of the target pre-mRNA.
The regulation of pre-mRNA splicing plays an import-
ant role in human pathologies (11). Impairment of the AS
is closely related to some disease mechanisms as in the case
of spinal muscular atrophy and myotonic distrophy.
Recently, new therapies aimed to correct defects arising
in pre-mRNA splicing, the so-called ‘splice-correction’ or
‘splice-modulation’ therapies, have been developed (12).
The accuracy of the AS depends on the stoichiometry
and interactions of positive and negative regulatory
proteins. Consequently, the identiﬁcation of the proteins
participating in the modulation of the AS is an essential
step to study the many aspects of gene expression.
Data from several laboratories demonstrate that some
alternative isoforms of mRNA-encoding ribosomal
proteins (rp) are NMD substrates. In Caenorhabditis
elegans, it has been shown that the AS of genes rpL3,
rpL12, rpL10 and rpL7 gives rise to aberrant mRNA
isoforms, which contain a PTC resulting from an incom-
plete intron removal, and are natural substrate of NMD
(13). The AS event appears conserved in humans and in
other mammals on rpL3 and rpL12 genes. In fact, we have
previously demonstrated that human rpL3 gene transcript
gives rise to a canonical mRNA and to an alternative
mRNA isoform containing a PTC targeted to decay by
NMD. rpL3 is able to modulate its own production via a
negative feedback loop. In fact, rpL3 overexpression
results in a decreased level of the canonically spliced
mRNA, and an increased production of the alternatively
spliced isoform (14). We have also identiﬁed the hnRNP
H1, as a transacting factor able to interact in vitro and
in vivo with rpL3 and with intron 3 transcript of the rpL3
gene. Our data demonstrated that hnRNP H1 is involved
in promoting the AS of human rpL3 pre-mRNA. In
addition, we have identiﬁed and characterized the
cis-acting regulatory elements, G runs, involved in
hnRNP H1-mediated regulation of splicing (15). In the
present study, we analyze the role of hnRNP H1 in the
rpL3 autoregulatory loop, and we report the identiﬁcation
of two new regulatory proteins, KHSRP (K-homology
splicing regulatory protein, also known as KSRP) and
NPM (Nucleophosmin, also known as B23, numatrin or
NO38), which exhibit opposite effects on the splicing
reaction of rpL3 pre-mRNA. Our data contribute to
shed light on protein–protein and RNA–protein inter-
actions within putative RNP complexes involved in the
modulation of splicing of the rpL3 gene.
MATERIALS AND METHODS
Cell cultures, transfections and drug treatment
Human cell line HeLa was cultured in Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM) with glutamax
(Invitrogen, Carlsbad, CA, USA) supplemented with
10% fetal bovine serum (FBS), 2mM L-glutamine and
penicillin–streptomycin 50U/ml.
L3–8 cell line, derived from rat PC12 Tet-Off cell line
and conditionally overexpressing rpL3 upon doxycyclin
removal (14), was grown in DMEM supplemented with
5% fetal calf serum (FCS), 10% horse serum, 2mM
L-glutamine and 100 mg/ml G418 (Invitrogen), hygromycin
200 mg/ml (USB, Santa Clara, CA, USA) and doxycyclin
10 ng/ml (Sigma, St Louis, MO, USA). The expression of
HA-rpL3 was induced upon removal of doxycyclin.
siRNA transfections were performed in HeLa cells
(1 106 cells, 6mm well plate) at a concentration of
150 nM by using Oligofectamine Reagent (Invitrogen) ac-
cording to the manufacturer’s instructions.
Plasmids were transfected in L3–8 cell line or in HeLa
cells (2.5 106 cells, 6mm well plate) by using
Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s instructions. Twenty-four hours after DNA or
siRNA transfections, cells were treated with 100 mg/ml
cycloheximide (CHX) for 4 h to block NMD. Then,
RNA and proteins were extracted by using the Trizol pro-
cedure (Invitrogen) for RT–PCR analysis and western
blot, respectively. Transfection efﬁciency was assessed by
cotransfecting a GFP-expressing vector and normalizing
RNA levels against GFP mRNA levels (data not shown).
DNA constructs and production of recombinant proteins
The cDNA of NPM was obtained by RT–PCR from
HeLa cells using the primers 50-ATGGAAGATTCGAT
GGAC-30 (forward) and 50-TTAAAGAGACTTCCTCC
A-30 (reverse), and cloned into a version of the eukaryotic
expression vector pcDNA4/HisMax C (Invitrogen) con-
taining the HA epitope, into the prokaryotic expression
vector pRSET-A (Invitrogen) containing the Histidine
tag, and in the prokaryotic expression vector pGEX4T3
(GE Healthcare, Waukesha, WI, USA). The cDNA of
hnRNP H1 was obtained by RT–PCR from HeLa cells
using the primers 50-ATGATGTTGGGCACGGAA-30
(forward) and 50-CTATGCAATGTTTGATTGAAAA-30
(reverse), and cloned into the prokaryotic expression
vector pRSET-A. The plasmids encoding GST-hnRNP
H1, GST-rpL3, HA-hnRNP H1, Flag-KHSRP and
pGEM4Z-Int3 were already available (15,16).
The recombinant proteins GST-hnRNP H1, GST-rpL3,
GST-rpL7a and GST were expressed in Escherichia coli
and puriﬁed by using glutathione Sepharose 4B beads
according to the manufacturer’s instructions (GE
Healthcare). The recombinant proteins His-NPM,
His-hnRNP H1 and His-rpL7a were expressed in E. coli
and puriﬁed by the nickel–nitrilotriacetic acid (Ni–NTA)-
Agarose chromatography according to the manufacturer’s
instructions (Qiagen, Valencia, California). His-tagged
KHSRP was expressed in Sf9 cells using the Baculovirus
system (Baculogold, BD Biosciences) and puriﬁed by
Ni–NTA-Agarose chromatography (16).
RNA interference
The target sequences of small interfering RNAs (siRNA)
in hnRNP H1 were: 50-GGAAATAGCTGAAAAGGC
T-30 and 50-CCACGAAAGCTTATGGCCA-30
(Ambion, Foster City, CA, USA). The siRNAs targeting
NPM and KHSRP were purchased from Santa Cruz
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Biotechnology (Santa Cruz Biotechnology, Santa Cruz,
CA, USA, sc-29771, sc-44831).
GST pull down
For GST pull-down assay, 50 mg of the fusion protein or
GST control, as bait were immobilized on glutathione-
Sepharose beads and incubated with 20 mg of the recom-
binant protein of interest in pull-down buffer (50mM
Tris–HCl, pH 7.5, 0.4mM EDTA, 150mM NaCl, 10%
glicerol, 1% NP-40, 1mM sodium-ortovanadate, 50mM
NaF, 5mM DTT and Protease Inhibitor Mix 1X) at 4C
for 1.5 h. The beads were washed extensively and boiled in
SDS sample buffer. The eluted proteins were loaded on
12% SDS–PAGE and analyzed by western blotting.
Immunoprecipitation and western blotting
For immunoprecipitation assay, 1mg of HeLa whole-cell
lysate was incubated with 30 ml of protein A/G agarose
beads coated with 5 mg of anti-NPM or anti-KHSRP
(Santa Cruz Biotechnology sc-47725, sc-33031) at 4C
for 12 h. The beads were washed and boiled in the SDS
sample buffer. The eluted proteins were loaded on 12%
SDS–PAGE and detected by western blotting. Aliquots of
protein samples (30 mg) were resolved by 12% SDS–gel
electrophoresis and transferred into nitrocellulose ﬁlters.
The membranes were blocked in PBS, 0.1% Triton and
5% dry milk for 2 h, and then challenged with anti-NPM,
anti-KHSRP, anti-hnRNP H1, anti-HA, anti-Flag (Santa
Cruz Biotechnology sc-10042, sc-57592 and sc-807) and
anti-rpL3 (Primm, Milan, Italy). The proteins were
visualized with enhanced chemiluminescence detection
reagent according to the manufacturer’s instructions
(Pierce, Rockford, IL, USA).
RNA pull-down assay
RNA pull-down assay was carried out by using adipic acid
dehydrazide beads. Brieﬂy, 20 mg of intron 3 RNA,
transcribed in vitro from pGEM4Z-Int3, were placed in
a 400 ml reaction mixture containing 100mM NaOAc
pH 5.2 and 5mM sodium m-periodate (Sigma), incubated
for 1 h in the dark at room temperature, ethanol
precipitated and resuspended in 100 ml of 100mM
NaOAc, pH 5.2. Then, 300ml of adipic acid dehydrazide
agarose beads 50% slurry (Sigma) equilibrated in 100mM
NaOAc pH 5.2 were added to this mixture, which was
then incubated for 12 h at 4C on a rotator. The beads
with the bound RNA were pelletted, washed twice with
1ml of 2M NaCl and equilibrated in washing buffer
(5mM HEPES pH 7.9, 1mM MgCl2, 0.8mM magnesium
acetate). The intron 3 RNA was then incubated with 50 mg
of each recombinant protein for 30min at room tempera-
ture in a ﬁnal volume of 0.6ml. The beads were then
washed four times in 1.5ml of washing buffer. Bound
proteins were eluted in SDS sample buffer loaded on a
12% gel for SDS–PAGE and analyzed by western
blotting.
RNP immunoprecipitation assay
For RNP immunoprecipitation assay (RIPA), HeLa cells
(2 106 cells) were lysed in 600 ml RIPA buffer 1 (10mM
Tris–HCl pH 7.5, 150mM NaCl, 0.1mM EDTA, 1mM
Na ortovanadate, 0.05M NaF, 0.5% NP-40) with
protease inhibitors mix 1 (Roche, Basel, Switzerland)
for 60min on ice, and then centrifuged at 10 000 g at
4C for 15min. The supernatant was subjected to a
pre-clearing step in which it was incubated with 50 ml of
protein A/G plus agarose for 1 h at 4C. The pre-cleared
cell extracts were then incubated with antibodies speciﬁc
for each protein (Santa Cruz Biotechnology) overnight at
4C. Protein A/G plus agarose beads (50 ml of 50% slurry)
were then added and the mix was incubated for 1 h at 4C
with gentle shaking and centrifuged. The immunopre-
cipitates were suspended in 100 ml TES buffer (10mM
Tris–HCl pH 7.5, 0.5mM EDTA, 0.5% SDS), incubated
at 65C for 10min and centrifuged for 1min at 10 000g.
Ten microliters of the supernatant were stored as
immunoprecipitated samples and subsequently
fractionated by SDS–PAGE to be analyzed by western
blotting. RNA was extracted from 90 ml using the Trizol
procedure (Invitrogen).
RT–PCR
For RT–PCR analysis, 1 mg of total RNA was reverse
transcribed into cDNA with the random hexamers tech-
nique using 200U of Superscript II RNAse H Reverse
Trancriptase (Invitrogen). The reaction was carried out at
42C for 50min and was terminated by heating to 75C
for 15min. Ten of the 40 ml of reaction mix were PCR
ampliﬁed in a ﬁnal volume of 50 ml, using 5 mM of each
speciﬁc primer, 10mM dNTPs and 0.5U of Taq DNA
polymerase (Invitrogen). Typically, 25–30 cycles of amp-
liﬁcation were performed. The primers were: rpL3-a 50-CT
CCGCTGGGCTCTGCCC-30 (forward) and 50-CTTCAG
GAGCAGAGCAGA-30 (reverse); rpL3-c 50-GGGCATT
GTGGGCTACGT 30 (forward) and 50-GTAAAGGCCT
TCTTCTTAG-30 (reverse); and b-actin 50-GGCACCACC
TTCTACA-30 (forward) and 50-CAGGAGGACAATGA
T-30 (reverse).
In separate experiments, we ascertained that the cycle
number was within the linear range of ampliﬁcations.
PCR products were visualized on 1% agarose gel con-
taining the ﬂuorescent Vistra Green dye (15). The
labeling intensity of the PCR product, which is linear to
the amount of DNA, was quantiﬁed using the
PhosphorImager (Bio-Rad, Haercules, CA, USA).
RESULTS
Interactions between NPM, KHSRP, hnRNP H1 and
rpL3 in vivo and in vitro
We have identiﬁed, by a proteomic analysis in a previous
study, proteins associated to rpL3 and/or to intron 3 tran-
script of the rpL3 gene, and we focused our studies on
proteins involved in RNA processing as putative compo-
nents of a RNP complex including rpL3 and mediating
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alternative splicing of the rpL3 pre-mRNA. Mass spec-
trometry results from GST pull-down experiments using
GST-rpL3 as bait demonstrated that NPM is one of
the proteins able to interact with rpL3 in vitro.
Conversely, KHSRP was not found associated to rpL3.
However, data obtained from RNA pull-down experi-
ments indicate that KHSRP is able to interact with the
intron 3 transcript of the rpL3 gene (15). Thus, we asked
whether NPM and KHSRP could be part of a RNP
complex including rpL3 through a direct or indirect inter-
action in vivo, by performing co-immunoprecipitation
assays.
Figure 1 shows the results of the experiments in which
NPM and KHSRP were speciﬁcally immunoprecipitated
from HeLa cells extracts by using antibodies against the
endogenous proteins. Immunoprecipitated proteins were
separated by SDS–PAGE and the presence of NPM and
KHSRP was investigated by western blotting in the recip-
rocally immunoprecipitated complexes. The results of
these experiments showed that NPM and KHSRP were
coimmunoprecipitated, thus indicating that they can asso-
ciate in vivo. Furthermore, a speciﬁc signal for rpL3
appeared both in NPM as well as in KHSRP
immunocomplexes. These data suggest that rpL3 is able
to interact in vivo with both proteins. Since we have pre-
viously demonstrated that hnRNP H1 is found included in
a complex with rpL3 and is involved in the regulation of
rpL3 gene alternative splicing (15), we looked for hnRNP
H1 in NPM and KHSRP immunoprecipitated complexes.
The presence of signal for hnRNP H1 in both immunopre-
cipitates was consistent with a speciﬁc association between
NPM, KHSRP and hnRNP H1. A control
immunoprecipitate obtained with anti-IgG antibodies
did not give any signal, when probed with anti-NPM,
anti-KHSRP, anti-rpL3 or anti-hnRNP H1 (Figure 1);
for a further control, see Supplementary Figure S1. In
the light of these results, it is plausible to hypothesize
that NPM, KHSRP, hnRNP H1 and rpL3 are associated
in a single quaternary complex; alternatively, NPM and
KHSRP could be part of independent protein
complexes, including or not rpL3, to which they are re-
cruited through different combination of protein–protein
interactions.
In an attempt to deﬁne a RNP complex including rpL3,
we investigated protein–protein interactions that rpL3
protein partners may establish within the complex. To
this aim, we performed GST pull-down assays by using
puriﬁed recombinant proteins. His-tagged proteins were
tested for their ability to bind to immobilized
GST-tagged proteins. GST-tagged proteins, and GST as
control, were immobilized using GSH-sepharose beads
and incubated with puriﬁed His-tagged proteins.
Western blot analysis was performed on each pull-down
sample. Figure 2 shows that His-hnRNP H1 was present
in the pull-down preparation of GST-NPM, but not in
those of GST-rpL3 or GST; His-NPM was detected in
the pull-down preparations of GST-rpL3, GST-hnRNP
H1, but not in that of GST; and His-KHSRP was
revealed in the pull-down preparations of GST-rpL3 and
GST-hnRNP H1, but not in those of GST-NPM or GST.
These results indicate that although a direct interaction
between rpL3 and hnRNP H1 has not been observed,
rpL3 and hnRNP H1 are able to interact directly with
NPM and KHSRP, while NPM and KHSRP are not
able to interact directly in the in vitro assay. No inter-
action whatsoever was detected with GST-rpL7a used as
a further control (data not shown).
Interactions between KHSRP, NPM, hnRNP H1 and
the intron 3 transcript in vivo and in vitro
Mass spectral analysis of our previous RNA pull-down
experiments revealed that KHSRP was able to interact
with intron 3 transcript of rpL3 gene in vitro (15). To
conﬁrm this interaction in vivo, we performed RNA
afﬁnity immunoprecipitation experiments. We speciﬁcally
immunoprecipitated KHSRP, and hnRNP H1 as con-
trol, from HeLa cell extracts by using monoclonal
antibodies against the endogenous proteins and searched
for the intron 3 transcript in the RNA–protein immuno-
precipitate complex (Figure 3A). Ampliﬁcation of the
signal corresponding to the intron 3 of rpL3 transcript,
but not of rpL7a gene transcript, by RT–PCR indicated
that KHSRP was able to bind with rpL3 pre-mRNA. The
absence of signal in the immunoprecipitate with anti-IgG
conﬁrmed the validity of this assay.
Although NPM was not found associated to the intron
3 transcript in vitro previously (15), we wondered
whether this interaction can occur in vivo. To this aim,
we speciﬁcally immunoprecipitated NPM from HeLa
cell extracts by using monoclonal antibodies against
the endogenous NPM. Analysis of RNA extracted
from the immunoprecipitate complex demonstrates that
NPM is able to precipitate the intron 3 transcript
(Figure 3A).
Next, in order to establish whether one or more among
the identiﬁed proteins was able to interact directly with
intron 3 RNA, or whether additional factors were
required, we performed RNA pull-down experiments by
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Figure 1. In vivo binding of NPM, KHSRP, hnRNP H1 and rpL3.
NPM or KHSRP were speciﬁcally immunoprecipitated from HeLa
cells extracts with antibodies against the endogenous NPM and
KHSRP. Immunoprecipitates were separated by SDS–PAGE and
immunoblotted with antibodies versus the indicated proteins. Note
the absence of signal in IgG immunocomplex. Results illustrated in
Figures 1–6 are representative of three independently performed
experiments.
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using puriﬁed recombinant proteins. For this purpose, a
transcript corresponding to the entire intron 3 of the rpL3
gene was used as bait and incubated with the puriﬁed re-
combinant proteins His-hnRNP H1 (control), His-NPM
or His-KHSRP and His-rpL7a as a control RNA binding
protein (17). Then, RNA-associated proteins were eluted
and analyzed by western blotting with antibodies against
the endogenous hnRNP H1, NPM, KHSRP and rpL7a.
The presence of signals speciﬁc for NPM and KHSRP
indicated that these two proteins are able to recognize
and bind to sequences in the rpL3 intron 3 transcript
(Figure 3B).
KHSRP regulates the alternative splicing of rpL3
pre-mRNA
The identiﬁcation of a speciﬁc interaction of KHSRP with
rpL3 and intron 3 transcript prompted us to investigate a
possible role of KHSRP in the rpL3 gene splicing. To this
aim, we analyzed the effects of the alteration in the expres-
sion levels of KHSRP on the rpL3 RNA splicing pattern.
Increasing amounts of a DNA construct expressing
Flag-KHSRP were transiently transfected in HeLa cells.
Twenty-four hours after transfection, cells were treated
with CHX to stabilize the alternatively spliced isoform
of rpL3 mRNA and lysed. Cells extracts were tested for
the detection of Flag-KHSRP levels by western blotting
with anti-Flag antibodies (Supplementary Figure S2A).
Total RNA from the same cell extract was analyzed by
RT–PCR using speciﬁc primers to amplify canonical
(rpL3-c) or alternative (rpL3-a) isoform of rpL3 mRNA.
We observed an increase in the rpL3-a mRNA level
correlated, in a dose-dependent mode, with increasing
amount of KHSRP (Figure 4A). These data indicate
that KHSRP positively affects the selection of the
30-cryptic splicing site within the intron 3 transcript of
rpL3 gene. Thus, we investigated the possibility that
KHSRP could act as a component of rpL3 autoregulatory
loop. We used L3–8 cells, a PC12 Tet-Off cell line stably
transfected with a vector containing the human
rpL3-coding sequence fused to the hemagglutinin (HA)
epitope-coding sequence (14). L3–8 cells were transiently
transfected with the DNA construct expressing
Flag-KHSRP. We chose a dose of Flag-KHSRP that
would result in about a 50% increase of the rpL3 alterna-
tive isoform mRNA. Twenty-four hours after transfec-
tion, we treated cells with CHX and induced the
expression of HA-rpL3 by removing doxycycline from
medium. Cells were then lysed and analyzed for the pro-
duction of Flag-KHSRP and HA-rpL3 by western
blotting using anti-Flag and anti-HA antibodies, respect-
ively (Supplementary Figure S2B). Total RNA was
analyzed by RT–PCR using speciﬁc primers to amplify
rpL3-c or rpL3-a mRNAs (Figure 4B). As previously
demonstrated the expression of the HA-rpL3 protein
resulted in an increase of the alternative isoform mRNA
(14). The expression of exogenous KHSRP also caused an
increase in rpL3-a mRNA level. Of interest, the increase in
the rpL3-a mRNA caused by overexpression of KHSRP
was greater after the induction of HA-rpL3 (Figure 4B).
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Figure 3. Analysis of the interactions of intron 3 of rpL3 pre-mRNA
with NPM and KHSRP, in vivo and in vitro. (A) In vivo binding of
intron 3 transcript to NPM and KHSRP. RT–PCR analysis, by using
primers against rpL3 intron 3 transcript and rpL7a RNA transcript, of
RNA extracted from the NPM, KHSRP, hnRNP H1 (control) and IgG
immunocomplexes. Note the absence of signal in IgG immunocomplex.
(B) In vitro binding of intron 3 transcript to hnRNP H1, NPM,
KHSRP and rpL7a. WB of RNA pull-down experiments, using
adipic acid dehydrazide agarose beads coated with intron 3 transcript
or unrelated RNA (Ctr RNA) incubated with puriﬁed proteins
His-hnRNP H1, His-NPM, His-KHSRP and His-rpL7a.
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The effects of KHSRP on rpL3 splicing were also
investigated in condition of mRNA silencing. L3–8 cells
were treated with siRNA speciﬁc for KHSRP and, 24 h
after transfection, cells were treated with CHX and
HA-rpL3 production was induced by removing doxycyc-
line from culture medium. Cells were then lysed and
protein extracts were analyzed for the expression of
KHSRP and HA-rpL3 by western blotting using
anti-KHSRP and anti-HA antibodies, respectively. As
shown in Supplementary Figure S2C, the decrease of
KHSRP level was 70% compared to the protein
amount detected in the control lysates. To examine the
effects of the reduced production of KHSRP on the
splicing pattern of rpL3 pre-mRNA, we analyzed total
RNA extracted from the same samples by RT–PCR
using speciﬁc primers to amplify rpL3-c and rpL3-a
mRNAs. As expected, in cells overexpressing rpL3, we
observed an increased level of rpL3-a mRNA isoform.
However, in cells, in which KHSRP had been silenced,
rpL3 induced overexpression was less effective in
promoting the production of rpL3-a mRNA isoform
(Figure 4C).
hnRNP H1 role in KHSRP-mediated activity
Since hnRNP H1 (15) and KHSRP have a role in
promoting the alternative splicing of rpL3 gene, we
asked whether a cooperation between these two proteins
would occur and favor the selection of 30-cryptic splicing
site, or whether their functions were redundant. To clarify
this issue, we switched off the expression of the gene
encoding hnRNP H1 by using RNA interference. To
this purpose, siRNAs against hnRNP H1 were transiently
transfected in L3–8 cells. Twenty-four hours after trans-
fection, cells were treated with CHX, induced for
HA-rpL3 production and harvested; RNA and proteins
were extracted. Lysates from cells transfected with
siRNA or untransfected were probed with hnRNP H1
antibodies. As shown in Supplementary Figure S3A, the
residual level of hnRNP H1 was 20% of the protein
detected in the control lysates. To investigate the effects
of the reduced production of hnRNP H1 on the splicing
pattern of rpL3 pre-mRNA, we examined the level of
rpL3 mRNA isoforms using RT–PCR. Under normal
conditions of rpL3 expression, the depletion of hnRNP
H1 resulted in a relevant decrease (80%) of the alterna-
tive mRNA (rpL3-a) level compared to controls. In con-
ditions of hnRNP H1 removal, rpL3, although
overexpressed, failed to activate the selection of the
30-cryptic splicing site (Figure 5A). These data indicate
clearly that hnRNP H1 plays a crucial role in triggering
the alternative splicing reaction of rpL3 pre-mRNA.
Next, we investigated a possible involvement of hnRNP
H1 in KHSRP-mediated activity. To this aim, we analyzed
the effects of hnRNP H1 depletion and KHSRP
overexpression on rpL3 splicing reaction. L3–8 cells
were transiently co-transfected with siRNA speciﬁc for
hnRNP H1 and a DNA construct expressing
Flag-KHSRP. Twenty-four hours after transfection, cells
were treated with CHX, induced for HA-rpL3 expression,
and harvested. hnRNP H1 and KHSRP protein levels
were detected by western blotting (Supplementary Figure
S3B). RNA extracted from the same lysates was analyzed
by RT–PCR. The Figure 5B shows that when hnRNP H1
was depleted, the enforced expression of KHSRP did not
cause an increase of rpL3-a mRNA level, either in normal
conditions of rpL3 expression, or in rpL3 overproduction.
These ﬁndings indicate that the ability of KHSRP to in-
ﬂuence the splicing of rpL3 pre-mRNA is mediated by
hnRNP H1.
NPM controls the alternative splicing of rpL3 gene
To study the functional relevance of the interactions of
NPM with rpL3 and intron 3 RNA in the control of the
rpL3 pre-mRNA splicing, we overexpressed NPM in
HeLa cells. Increasing amounts of a DNA construct ex-
pressing HA-NPM were transiently transfected in HeLa
cells. Twenty-four hours after transfection, cells were
treated with CHX and lysed. The expression levels of
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Figure 4. (A) Effects of KHSRP overexpression on rpL3-a mRNA
levels in HeLa cells. Representative RT–PCR analysis of total
RNA from CHX-treated HeLa cells untransfected or transfected
with increasing amounts of Flag-KHSRP. (B) Effects of KHSRP
overexpression on rpL3-a mRNA levels in L3–8 cells. Representative
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depletion of KHSRP on rpL3-a mRNA levels in L3–8 cells.
Representative RT-PCR analysis of total RNA from CHX-treated
L3–8 cells untransfected or transfected with KHSRP-siRNA, NI or
induced I for HA-rpL3 expression from the same samples. The levels
of rpL3-a mRNA were quantiﬁed by PhosphorImager (Bio-Rad) and
normalized to b-actin levels.
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the recombinant fusion protein were detected by western
blotting using anti-HA antibodies (Supplementary Figure
S4A). The pattern of the spliced rpL3 gene transcript was
monitored by RT–PCR by using speciﬁc primers to
amplify rpL3-c and rpL3-a isoforms of rpL3 mRNA. As
shown in Figure 6A, NPM overexpression caused a
dose-dependent decrease of rpL3-a mRNA amounts.
Next, to investigate the role of NPM in the context of
rpL3 autoregolatory loop, we performed experiments of
overexpression and RNAi-mediated silencing of NPM in
L3–8 cell line. Cells were transiently transfected with a
DNA vector expressing HA-NPM. We chose a dose of
HA-NPM that would result in about 50% decrease of
the rpL3-a mRNA isoform. Twenty-four hours after
transfection, cells were treated with CHX and induced
to express HA-rpL3. Cells were then lysed and analyzed
for the production of HA-NPM and HA-rpL3 by western
blotting by using anti-HA antibody (Supplementary
Figure S4B). Total RNA from the same samples was
analyzed by RT–PCR by using speciﬁc primers to
amplify rpL3-c and rpL3-a isoforms of rpL3 mRNA.
The overexpression of NPM resulted in a reduction in
the rpL3-a mRNA amount in normal conditions of rpL3
expression, and prevented the increasing of rpL3-a mRNA
level when rpL3 protein was overexpressed (Figure 6B).
To investigate the effects of NPM removal on rpL3 gene
splicing, NPM expression levels were reduced by transfect-
ing L3–8 cells with speciﬁc siRNA. Twenty-four hours
after transfection, cells were treated with CHX and
induced to express HA-rpL3. Protein extracts from cells
were tested for the production of HA-NPM and HA-rpL3
by western blotting (Supplementary Figure S4C). Total
RNA was analyzed by RT–PCR by using speciﬁc
primers to amplify rpL3-c and rpL3-a mRNA isoforms.
B
+
β-actin
rp
L3
-
a
m
R
N
A
A
rb
itr
a
ry
u
n
its
siRNA hnRNP H1 -- +
Flag-KHSRP - - ++
HA-rpL3 - + - +
+
RT-PCR
NI
I
siRNA hnRNP H1
Flag-KHSRP
-
+-
4
6
8
10
12
0
2
rpL3-a
rpL3-c
β-actin
rpL3-a
rpL3-c
A
siRNA hnRNP H1 -- ++
HA-rpL3 - + - +
NI
I
siRNA hnRNP H1
- +
rp
L3
-
a
m
R
N
A
A
rb
itr
a
ry
u
n
its
4
6
8
10
12
0
2
RT-PCR
Figure 5. (A) Effects of RNAi-mediated depletion of hnRNP H1 on
rpL3-a mRNA levels in L3–8 cells. Representative RT-PCR analysis of
total RNA from CHX-treated L3–8 cells, untransfected or transfected
with hnRNP H1-siRNA, NI or induced I for HA-rpL3 expression.
(B) Effects of RNAi-mediated depletion of hnRNP H1 and KHSRP
overexpression on rpL3-a mRNA levels in L3–8 cells. Representative
RT–PCR analysis of total RNA from CHX-treated L3–8 cells
untransfected or cotransfected with hnRNP H1-siRNA and
Flag-KHSRP, NI or induced I for HA-rpL3 expression. The levels of
rpL3-a mRNA were quantiﬁed by PhosphorImager (Bio-Rad) and
normalized to b-actin levels.
RT-PCR
rp
L3
-
a
A
rb
itr
a
ry
u
n
its
β-actin
0.5 210
A
0.5 2 μg10
4
6
8
10
12
0
2
rpL3-a
rpL3-c
HA-NPM (μg)
β-actin
rp
L3
-a
 m
R
N
A
A
rb
itr
ar
y 
un
its
HA-NPM +
-
-
HA-rpL3
- + - +
RT-PCR
NI
I
HA-NPM
- +
4
6
8
10
12
0
2
rpL3-a
rpL3-c
+
β-actin
rp
L3
-a
 m
R
N
A
A
rb
itr
ar
y 
un
its
siRNA NPM -- ++
HA-rpL3 - + - +
RT-PCR
NI
I
siRNA NPM -
4
6
8
10
12
0
2
rpL3-a
rpL3-c
CB
+
Figure 6. (A) Effects of NPM overexpression on rpL3-a mRNA levels
in HeLa cells. Representative RT–PCR analysis of total RNA from
CHX-treated HeLa cells untransfected or transfected with increasing
amounts of HA-NPM. (B) Effects of overexpression of NPM on
rpL3-a mRNA levels in L3–8 cells. Representative RT–PCR analysis
of total RNA from CHX-treated L3–8 cells untransfected or trans-
fected with HA-NPM, NI or I for HA-rpL3 expression. (C) Effects
of silencing of NPM on rpL3-a mRNA levels in L3–8 cells.
Representative RT–PCR analysis of total RNA from CHX-treated
L3–8 cells untransfected or transfected with siRNA against NPM, NI
or I for HA-rpL3 expression. The levels of rpL3-a mRNA were
quantiﬁed by PhosphorImager (Bio-Rad) and normalized to b-actin
levels.
7582 Nucleic Acids Research, 2011, Vol. 39, No. 17
In physiological conditions of rpL3 expression, following
NPM depletion, the production of rpL3-a mRNA
appeared restored above the control expressing NPM.
Thus, as expected, HA-rpL3 expression upon NPM
silencing caused a signiﬁcant increase of rpL3-a mRNA
levels (Figure 6C).
DISCUSSION
AS of mRNA is mainly responsible for a variety of gene
products much larger than expected from the number of
genes. It has been estimated that >90% of human genes
are alternatively spliced (18,19). However, a number of
splicing events give rise to mRNA isoforms containing a
PTC that are targeted for decay by NMD. Accumulating
data indicate that association of AS and NMD
(AS-NMD) may result in a quantitative post-
transcriptional regulation of gene expression (7).
In eukaryotes rp expression is regulated by multiple
control mechanisms, mostly at post-transcriptional and
translational level in order to maintain ribosome biosyn-
thesis at the level appropriate to growth conditions and
requirements of the cell (14,15,20,21). However, several
reports indicate that rp, in addition to the role as compo-
nents of the translation machinery, exert a variety of
extraribosomal functions, for which additional, speciﬁc
regulatory strategies are required (22,23). Autoregulation
may represent an efﬁcient mechanism to control the level
of a single protein; we have demonstrated previously a role
of AS-NMD in the regulation of the rpL3 gene expression,
promoted by rpL3 protein itself as part of an
autoregulatory negative-feedback loop (14,15).
In an attempt to understand the mechanism of the regu-
latory strategy, we focused our studies on the identiﬁca-
tion of protein partners of the rpL3 protein, and to the
analysis of their contribution to the process. Our previous
results demonstrated that rpL3 protein, within a RNP
complex including the constitutive splicing factor
hnRNP H1, promotes the alternative splicing reaction of
its own gene (15). In most cases, the choice of a splicing
site is made by a dynamic and complex combination of
different splicing regulators; in fact, the function of an
individual splicing factor may be different depending on
interacting partners present in the regulatory network.
The identiﬁcation of new regulatory proteins and the
mapping of protein–protein interactions within the RNP
complex including rpL3 are crucial steps to understand
the molecular mechanism involved in the selection of the
cryptic 30-splice site within intron 3 transcript of the rpL3
gene. To this aim, we analyzed occurrence of interaction
between rpL3 and putative protein partners previously
identiﬁed through a proteomic analysis (15), and the role
of these proteins in the autoregulatory network of rpL3
expression. Our data provide an insight in putative RNP
complexes including hnRNP H1, rpL3 protein,
pre-mRNA of rpL3 gene, and the newly identiﬁed
protein factors, NPM and KHSRP, involved in the regu-
lation of rpL3 gene expression via AS-NMD.
NPM is a nucleolar, ubiquitous and multifunctional
phosphoprotein. NPM is involved in multiple biological
functions including the ribosome biogenesis, the control of
cell cycle progression and centrosome duplication. The
cellular activities of NPM are tightly regulated by
multiple factors that seem to be speciﬁc for each
function. Post-translational modiﬁcations, oligomeriza-
tion and hetero-oligomerization strongly inﬂuence the
cellular functions of NPM (24). Emerging evidences
indicate a functional correlation between NPM and
some rp, independent from ribosome biogenesis or its
assembly (25,26). It is known that NPM is involved in
both positive and negative regulation of transcription,
and a possible role of NPM in the splicing process has
been suggested (27). To our knowledge, the present
study demonstrates for the ﬁrst time a role of NPM as
splicing factor.
KHSRP is a multifunctional RNA-binding protein that
has been mainly implicated in post-transcriptional regula-
tion, mRNA decay and maturation of microRNA precur-
sors (28,29). There are few data supporting an
involvement of KHSRP in the splicing control (30,31).
Analysis of immunoprecipitate of NPM and KHSRP in
HeLa cell extracts showed that NPM and KHSRP
coimmunoprecipitate together with rpL3 and hnRNP
H1, indicating that these proteins associate in vivo,
although the occurrence of multiple complexes including
different combination of protein interactions cannot be
excluded (Figure 1). In addition, in vitro GST pull-down
experiments (Figure 2) demonstrated that NPM and
KHSRP are able to recognize and bind rpL3 and
hnRNPH1, whereas a direct binding between NPM
and KHSRP, or rpL3 and hnRNPH1 has not been
observed.
On the other hand, RNA immunoprecipitation assays
indicated the presence of intron 3 RNA in the
immunoprecipitate of NPM and KHSRP, and RNA
pull-down experiments showed that NPM and KHSRP
are able to contact directly the intron 3 RNA (Figure 3)
as previously shown for hnRNP H1 (15). Taken together,
these data strongly suggest that NPM and KHSRP are
involved in the control of the splicing of rpL3.
Our analysis of the effects of individual expression of
NPM, hnRNP H1 or KHSRP provided an insight also on
the speciﬁc role of each protein factor on the rpL3 gene
splicing. In the context of rpL3 autoregulatory circuit,
protein overexpression data indicated that KHSRP repre-
sents a positive regulator of the alternative splicing that
cooperates with rpL3 and hnRNP H1 in the activation of
30-cryptic splice site (Figure 4). However, silencing of
KHSRP caused only 20% decrease of the alternative
mRNA isoform produced when rpL3 is overexpressed,
suggesting that KHSRP is not a crucial player in the
rpL3 autoregulatory loop (Figure 4). Instead, when
hnRNPH1 expression was silenced, rpL3 overexpression
failed to result in the activation of cryptic the 30-splice site
(Figure 5A). These ﬁndings together with the observation
that KHSRP, even in excess, was unable to increase the
alternative mRNA isoform in the absence of hnRNP H1
strongly indicate that hnRNP H1 is the key component of
rpL3 autoregulatory loop, while KHSRP might play a role
as an enhancer of hnRNP H1-mediated activation of rpL3
gene alternative splicing (Figure 5B).
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It is known that the RNA binding activity of KHSRP is
mediated by four KH domains. Among these, KH1 and
KH3 domains recognize and bind speciﬁcally to a G-rich
target (UGGG and GGGU, respectively) (32). The
analysis of the human intron 3 transcript sequence
showed that G6 motif, an essential element for the
splicing regulatory activity of hnRNP H1, could represent
also a binding site for KH1 or KH3. In addition, the
UGCAUG element, essential to the binding of KHRSP
to src-DCS (Downstream Control Sequence), is also
present in the sequence of intron 3 RNA and it is
located close to the hnRNP H1 binding site G3 and G6
motifs (31). Consequently, it seems plausible to speculate
that KHSRP might interact with these sequences within
intron 3 transcript as well as with hnRNP H1 making
more stable and efﬁcient the association of hnRNP H1
with intron 3 RNA.
Unlike hnRNP H1 and KHSRP, NPM behaves as a
negative regulatory factor of rpL3 gene alternative
splicing (Figure 6). It is possible that the inhibitory
effect of NPM on alternative splicing might be due to a
‘bind and block’ mechanism. In fact, NPM could interact
with sequences within intron 3 pre-mRNA, perhaps in the
vicinity of hnRNP H1 binding sites, and sterically block
the access of hnRNP H1, thus preventing its interaction
with G3 and G6 elements. Since binding of hnRNP H1 to
G-runs site has been demonstrated crucial, the alternative
splicing of rpL3 gene would be negatively affected.
Alternatively, in the light of results demonstrating an
interplay among different protein factors, possibly
assembled in multiple RNP complexes, we propose a
working model, which overcomes the model proposed pre-
viously (15). The model predicts the existence of, at least,
two complexes whose protein composition depends on
rpL3 protein levels. When cell functions require an efﬁ-
cient production of rpL3, the interaction of NPM with
intron 3 pre-mRNA might affect its secondary structure
and mask the binding sites of hnRNP H1. At the same
time, repression of AS might be enforced by a concomi-
tant direct binding of NPM to the positive regulator factor
hnRNP H1 (Figure 7A).
When rpL3 levels exceed cell requirements for rpL3
ribosomal as well as extraribosomal functions, the
protein could interact with NPM; consequently, NPM
would be released from the RNP complex to which rpL3
could be associated by interacting with KHSRP. The
removal of NPM, and the rearrangement of the inter-
actions within the RNP complex, could make available
the enhancer unit G3+G6 within intron 3 transcript
and, at the same time, the presence of rpL3 in the re-
modeled complex could induce conformational changes
that favor the interaction of hnRNP H1 with G3+G6.
Finally, such complex could promote the activation of
the alternative mode of splicing reaction (Figure 7B).
At the present, the challenge is to determine the hier-
archy of interactions leading to the assembly of RNP
complexes, and the dynamic nature of protein–protein
interactions causing the remodeling of complexes respon-
sible for the modulation of the splicing of the rpL3 gene.
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